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Abstract 
L’ attività di ricerca del Dottorato di Ricerca in Scienze Veterinarie, XXIX 
ciclo, si inserisce nell’ambito dello studio chimico-biologico di piante 
medicinali, rivolto all’isolamento e alla caratterizzazione strutturale dei 
metaboliti secondari da matrici vegetali e alla valutazione di un loro utilizzo 
in ambito veterinario ed alimentare. Le specie oggetto di studio sono 
utilizzate nella medicina popolare o in medicina veterinaria per le loro 
proprietà biologiche, per la cura di comuni patologie in particolare 
parassitosi e/o infezioni batteriche. 
L’indagine chimica biologica si è concentrata sulle seguenti specie vegetali: 
• Psiadia punctulata (DC.) Vatke della famiglia delle Asteraceae, 
diffusa nelle zone aride tropicali, nelle praterie e nei pascoli aridi 
arbustivi, fino ai margini della foresta, dell’Africa Sud-Orientale, e 
in Medio Oriente, alcune piante di questa famiglia sono ampiamente 
usate come antimicrobici. 
• Hypoestes forskaolii (Vahl) Roem. & Schult, pianta erbacea 
appartenete alla famiglia delle Acanthaceae, ampiamente distribuita 
in tutta la regione meridionale dell'Arabia Saudita, alcune piante di 
questa famiglia sono ampiamente usate come antielmintici. 
• Trichilia maynasiana C.DC appartenente alla famiglia delle 
Meliaceae è un albero ampiamente distribuito nelle zone tropicali del 
Sud-Africa usato in medicina popolare per il trattamento di vari 
disturbi in particolare antiinfiammatorio, purgante, antiepilettico e 
antipiretico; 
• Vernonia nigritiana Oliv. & Hiern. (Asteraceae) è una pianta 
erbacea o arbusto ampiamente distribuito in Africa occidentale, le 
foglie e altre parti della pianta sono tradizionalmente utilizzate 
contro le infiammazioni della pelle, reumatismi, febbre, cefalea e 
insufficienza. In medicina etnoveterinaria molte piante del genere 
Vernonia sono usate per infezioni batteriche ed elmintiasi. 
La purificazione e l’isolamento dei metaboliti secondari è stata realizzata 
mediante l’utilizzo di tecniche cromatografiche quali: cromatografia su 
colonna, cromatografia su strato sottile, HPLC (High Pressure Liquid 
Chromatography). La caratterizzazione strutturale di tutti i composti isolati 
è stata ottenuta principalmente attraverso tecniche spettroscopiche di 
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Risonanza Magnetica Nucleare con esperimenti monodimensionli (1H-
NMR, 13C-NMR) e bidimensionali (COSY, HSQC, HMBC, ROESY), e 
tecniche di spettrometria di massa. L’analisi ha condotto all’isolamento di 
diversi metaboliti secondari per ciascuna delle specie vegetali in esame, 
alcuni dei quali a struttura non nota in letteratura. 
Lo studio fitochimico di Psiadia punctulata ha consentito 
l’isolamento e la caratterizzazione strutturale di 30 composti tra diterpeni 
kauranici, trachilobanici e flavonoidi, 13 di questi non sono mai stati 
descritti in letteratura ed appartengono alla classe dei diterpeni ent-kaurani 
e trachilobani. L'attività antimicrobica dell'estratto diclorometanico di 
Psiadia punctulata è stata valutata contro batteri Gram-positivi 
(Staphylococcus aureus) e Gram-negativi (Pseudomonas aeruginosa) ed il 
fungo dimorfico Candida albicans. I risultati hanno mostrato un'attività 
antibatterica dell'estratto contro S. aureus (MIC50 = 100 ug/mL), mentre 
nessuna attività è stata rilevata contro i batteri Gram-negativi. Inoltre, 
l'estratto ha mostrato una attività antifungina nei confronti di C. albicans 
con MIC2 = 50 µg / mL e MIC0 = 130 µg / mL. Le nove frazioni A-I ottenute 
dopo separazione su colonna di gel di silice sono state testate per la loro 
attività antimicrobica alle dosi (da 20 a 100 µg/ml), le frazioni A,B e I sono 
risultate inattive, le frazione C-H hanno mostrato un interessante attività 
antimicrobica nei confronti di Staphylococcus aureus e Candida albigans 
(MIC2 15 µg/mL ma non nei confronti di Pseudomonas aeruginosa. Tutte 
le molecole isolate dalle frazioni attive sono state investigate per l’attività 
antimicrobica, solo 4 molecole, 3 flavonoidi e un diterpene hanno mostrato 
un interessante attività.  In particolare Il composto 3, 3',4',5,7-
tetramethoxyflavone, alla concentrazione di 40 μg/mL è stato capace di 
inibire del 50% la produzione di biofilm di S. aureus e del 90% per Candida 
albicans.  
Lo studio fitochimico delle foglie di H. forskaolii ha permesso di 
isolare 13 composti appartenenti alla classe dei diterpeni fusicoccanici ed 
isopimarani, 4 di questi diterpeni fusicoccanici non sono mai stati scoperti 
precedentemente in natura. Gli estratti n-esananico, cloroformico, 
cloroformio:metanolo 9:1 e metanolico di Hypoestes forskaolii sono stati 
testati nel saggio in vitro di attività antielmintica Egg Hacth Assay su diverse 
specie di nematodi gastrointestinali che naturalmente parassitano i piccoli 
ruminananti. Gli estratti polari non sono stati in grado di mostrare attività 
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ovicida significativa (meno del 50% di schiusa delle uova), mentre estratto 
n-esano alla concentrazione di 1 mg/ml ha mostrato una moderata inibizione 
della schiusa delle uova del 30%. Successivamente i composti isolati sono 
stati testati per la valutazione del loro potere antiproliferativo in vitro su due 
linee cellulari quali HeLa e Jurkat U973 ma tutti i composti testati non hanno 
influenzato significativamente la crescita e la vitalità cellulare. 
Lo studio di Trichilia maynasiana ha condotto all’isolamento di 9 
composti di cui 2 molecole mai isolate in precedenza a struttura tirucallanica 
e secoguaianica. 
Lo studio fitochimico condotto su Vernonia nigritiana ha portato 
all’isolamento di 7 composti di cui 2 lattoni sesquiterpenici mai isolati in 
precedenza. 
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The research activity of the PhD project in Veterinary Science was aimed at 
the isolation and structural characterization of secondary metabolites from 
medicinal plants and the evaluation of their use in veterinary science. The 
selected plants are species used in folk medicine or in the veterinary 
medicine, particularly plants used as antiparasitic and antimicrobial  
The chemical-biological investigation was carried out on the following 
plants:  
• Psiadia punctulata (DC.) Vatke of the Asteraceae family it is found 
in tropical arid areas from the grasslands and shrubs in arid pastures 
to the edge of the forest, South-Eastern Africa, and Middle East, 
some plants of this family are widely used as antimicrobial; 
• Hypoestes forskaolii (Vahl) Roem. & Schult, herbaceous plant 
belonging to the Acanthaceae family, widely distributed throughout 
the southern region of Saudi Arabia, some plants of this family are 
widely used as a natural anthelmintic; 
• Trichilia maynasiana C.DC belonging to the family of the Meliaceae 
is a tree widely distributed in tropical areas of South Africa used in 
folk medicine to treat various anti-inflammatory diseases; 
• Vernonia nigritiana Oliv. & Hiern. (Asteraceae) is an herbaceous 
plant or shrub widely distributed in West Africa, the leaves and other 
parts of the plant are traditionally used against skin inflammations, 
rheumatism, fever, headache and impairment. In veterinary medicine 
many plants of Vernonia genus are  used for bacterial infections and 
intestinal worms. 
The isolation of secondary metabolites was achieved by chromatographic 
techniques such as column chromatography, thin layer chromatography, 
HPLC (High Pressure Liquid Chromatography). The structural 
characterization of all the isolates was performed by spectroscopic 
techniques, nuclear magnetic resonance experiments monodimensional (1H-
NMR, 13C-NMR) and two-dimensional (COSY, HSQC, HMBC, ROESY), 
and mass spectrometry. 
The investigation of Psiadia punctulata led to the isolation of 30 
compounds including diterpenes and flavones, of which 13 were new natural 
compounds. The antimicrobial activity of the dicloromethan extract was 
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tested against Gram-positive bacteria (Staphylococcus aureus), Gram-
negative (Pseudomonas aeruginosa) and dimorphic fungus Candida 
albicans. The results of this study highlighted that the dicloromethan extract 
showed antibacterial activity against S. aureus (MIC50 = 100 ug/mL), 
whereas no activity was detected against Gram-negative bacteria. Moreover, 
the extract showed antifungal activity against Candida albicans (MIC2 = 50 
µg/mL and MIC0 = 130 µg/mL). The nine fractions A-I obtained after a 
silica gel column separation were tested for their antimicrobial activity at 
doses ranged from 20 to 100 µg/ml. The A,B and I fractions were found to 
be inactive on all species, instead six fractions (C-H) showed a remarkable 
activity. All the compounds isolated from active fractions were tested for 
their antimicrobial activity. Compound 3, 3',4',5,7-tetramethoxyflavone, at 
a concentration of 40 g/mL was able to inhibit by 50% the production of 
biofilm of the S. aureus and 90% for Candida albigans. 
The phytochemical investigation of H. forskaolii leaves led to the 
isolation of 13 compounds belonging to the class of diterpenes fusicoccane 
and isopimarane, among these 4 of fusicoccane diterpenes are new natural 
compounds. The n-hexane, chloroform, chloroform: methanol 9:1 and 
methanolic extracts of Hypoestes forskaolii were tested fot in vitro 
anthelmintic activity via Egg hacth Assay on different species of 
gastrointestinal netamathodes that naturally parasitize small ruminants. 
Polar extracts have not been able to show significant ovicidal activity (less 
than 50% of hatching), while the n-hexane extract at a concentration of 1 
mg/ml showed moderate inhibition of 30% hatching. All the isolated 
compounds were also tested in vitro for the antiproliferative activity on 
HeLa and Jurkat U973 cell lines, all compounds did not significantly affect 
growth and cell viability. 
The phytochemical investigation of Trichilia maynasiana led to the 
isolation of nine compounds of which two are new natural compounds. 
These compounds belonging to the class of tirucallane and secoguaiane 
terpenes. 
The phytochemical study of V. nigritiana led to the isolation of seven 
secondary metabolites including two sesquiterpene lactones, never 
described before.
Introduction 
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Introduction 
Plants are the source of an almost uncountable numbers of secondary 
metabolites, characterized by different chemical structures and a broad 
range of biological activity. Only in the last decade the role of secondary 
metabolites has been deeply evaluated and studied. Today, with the word 
“secondary metabolites” or “specialized metabolites” we indicate 
compounds nor directly involved in the primary metabolism of the plant, 
such as growing and reproduction, nor simple catabolic products. In fact, 
there are experimental evidence that they have an important role in the 
evolution. Nowadays, the research in the field of biology, chemistry, and 
medicine, is directed towards the identification and structural 
characterization of plant secondary metabolites with pharmacological 
activity with the aim of discover their detailed biosynthesis pathways and as 
a molecular lead for their industrial production or the synthesis of new drugs. 
The industrial interest towards active compounds of natural origin is related 
to the increasing request of natural products (especially in developed 
countries) instead of synthetic molecules (Gullo, A.M., et al,1994, Newman 
and Cragg, 2016). 
Therefore, plant biodiversity represents the richness and complexity of the 
earth life and it’s the major resource that nature gave to the development of 
human life. More than 250.000 species of plants have already been identified 
but we think that more than 50.000 species are still unknown and should be 
characterized. Moreover, within the 100 cultivated species that produce food 
and crops, the traditional farmer selected and developed hundreds of 
thousands different gene varieties. Natural products have provided, and 
continue to provide food, fats, colouring materials, tissues, and molecules 
used for the treatment of numerous diseases. 
The human activity became so destructive of the earth’s resources (the world 
population is about 6 billion people and their consumption is the 40% of the 
annual global production) that the biodiversity of the ecosystems has been 
substantially stressed and threatened with the permanent loss of species, 
varieties, and groups. The 20th century was the most destructive of the 
earth’s resources and it’s estimated that in this century each year about a 
thousand of species become extinct. This means that we are living a period 
of continuing destruction and degradation of the environment that will result 
in the irretrievable loss of many forms of biogenetic diversity. World 
Conservation Union estimates indicate that one out 8 of the 240.000 plant 
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species become extinct. The 90% of this species is endemic of a country, 
thus it means that doesn’t grow anywhere (Blunt et al., 2014; Shu, 1998) 
The preservation of biodiversity throughout the world is of importance to 
the human population and to the stability of the entire world. Plant 
biodiversity plays an important role in providing household food security. 
There is increasing recognition of the important roles plant biodiversity 
(including underutilized species) can play in ensuring food security, 
veterinary medicine and better health (provision of vitamins and other 
micro-nutrients to combat hidden hunger), supporting income generation 
and local economy (meeting increasing demand for diversity for food and 
other products), providing non material benefits (link to cultural traditions 
and local knowledge) and ecosystem health (mitigation of adverse effects 
due to environmental changes). The discovery and development of 
pharmaceutical and other useful agents from natural products research can, 
under appropriate circumstances, promote economic opportunities and 
enhanced research capacity in the South of the world. Natural products 
research should promote the self-sustainability of the research activities, 
generating income derived from the intellectual property of the scientific 
discoveries (Jensen, 2016; Kaufman et al., 1999; Sethi, 1998). 
I.I Ethnoveterinary-medicine and animal self-medication 
The rural and tribal people are not easily accessible to modern veterinary 
services for their livestock considering that livestock production is the major 
source of income in rural and semi urban areas of Third World countries. 
Farmer are less economically healthy to cope with various bovine ailments 
therefore they depend upon their traditional knowledge of healing animals. 
The use of plants could be a cheap, safe, biodegradable and easily accessible 
alternative to the synthetic and modern methods of disease control. 
Livestock owners use a variety of plants and their products to form 
traditional medicines for primary health care treatment and maintaining 
animals productive. Knowledge of the local farmers and tribe have thus laid 
the foundations take a part in a much bigger concept named ethno-veterinary 
(SriBalaji and Chakravarthi, 2010). 
Ethno-veterinary medicine has evolved through observations, trials and 
errors, and passes from one generation to the next through verbal 
communication. Therefore, these practices are hardly documented and 
unfortunately largely lost, diluted and distorted. In order to understand its 
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scientific justification, logic and to develop new concepts, it is of utmost 
need and importance to document the practices involved in EVM. The 
traditional knowledge of animal healthcare practices requires great attention 
for pharmaceutical analysis to prospect new drugs in the concerned (Gaur et 
al., 2010). 
When the problem is to discover new chemicals, it would be useful to 
observe wild animals (and domesticated ones too) as well as carrying out 
randomized prospection on rainforest plants, or interviewing indigenous 
peoples about their traditional healing knowledge and practices, since 
animals can give good indications about new sources of medicines 
(Huffman, 2003; Huffman and Vitazkova, 2007). 
Early in the co-evolution of plant-animal relationships, some arthropod 
species began to utilize the chemical defences of plants to protect themselves 
from their own predators and parasites. It is likely, therefore, that the origins 
of herbal medicine have their roots deep within the animal kingdom. From 
prehistoric times man has looked to wild and domestic animals for sources 
of herbal remedies. Both folklore and living examples provide accounts of 
how medicinal plants were obtained by observing the behaviour of animals. 
According to primatologist Michael Huffman, “the probability that animals 
may have something to teach us about the medicinal use of plants is quite 
high” (Biser, 2006). Field researchers have observed different species of 
animals seeking and using substances in such a way as to enhance their own 
health. This behaviour was called as animal self-medication (Confessor et 
al., 2016). 
To date, perhaps the most striking scientific studies of animal self-
medication have been made on the African great apes. The great ape diet is 
often rich in plants containing secondary compounds of non-nutritional, 
sometimes toxic, value that suggest medicinal benefit from their ingestion. 
Chimpanzees (Pan troglodytes), bonobos (Pan paniscus) and gorillas 
(Gorilla gorilla) are known to swallow whole and defecate intact leaves. 
The habit has been shown to be a physical means of purging intestinal 
parasites. Chimpanzees and man coexisting in sub-Saharan Africa are also 
known to ingest the bitter pith of Vernonia amygdalina for the control of 
intestinal nematode infections (Costa-Neto, 2012). 
In light of the growing resistance of parasites and pathogens to synthetic 
drugs, the study of animal self-medication and ethno-medicine offers a 
novel line of investigation to provide ecologically-sound methods for the 
treatment of parasites using plant-based medicines in populations and their 
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livestock living in the tropics. Phytochemical studies have shown a wide 
range of biologically active properties of medicinal plants also applicable in 
the field of veterinary medicine. 
 
I.II Natural compounds in veterinary medicine 
The recent return to “natural medicine” has emphasized the importance of 
gathering information about medicinal plants traditionally used to treat 
animals. Phytotherapy represents one of the most used non- conventional 
medicines in both human and veterinary medicine. It utilizes plants, parts 
of them such as flowers, leaves, roots, and seeds, and substances extracted 
from them to treat many different minor diseases (Abbass et al., 1994; 
Anon, 1996; Viegi et al., 2003) (Fig. 1). 
 
 
Fig. 1 Organs of the plant most used in veterinary practices 
Medicinal properties of the plants are due to the large amount of active 
compounds that can be found in the vegetable kingdom. Often, active 
principles extracted from plants are equivalent to synthetic drugs according 
to their therapeutic efficacy; for this reason they are utilized in veterinary 
medicine, mainly as antibacterial, antimycotic, antiparasitic, disinfectants 
and immunostimulants. 
Regarding large animals, natural compounds and phytotherapy are mainly 
utilized in organic farms to reduce the use of allopathic drugs more and 
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more. For the animal market many of the currently used antimicrobial, feed 
additive antibacterial, endectocide and anticoccidial drugs are either natural 
products or synthetics based on natural products (Ruddock, 2000). The 
majority of these natural products are produced from the fermentation broth 
of microorganisms, though plants have also been an important source of 
bioactives. There is an increasing public concern regarding the use of 
pharmaceuticals in the animal industry. Much of this has been as a result of 
the emergence of drug resistance. A particular area of criticism has been in 
the use of antibiotics as growth promoters and the associated risk of 
developing antibiotic resistance in human pathogens (Barton 2000). In 
organic farms, not only herbal drugs such as plant extracts and essential oils, 
but also homeopathic products, nutraceuticals and oligoelements, such as 
sodium, calcium, phosphorus, magnesium, and sulfur, are considered the 
main drugs to administer to animals for the treatment of different diseases. 
Nevertheless, it is possible to use synthetic allopathic drugs only when the 
previous products are ineffective; in such an eventuality, it is preferable to 
choose drugs that are metabolized rapidly, with a low environmental impact 
and less adverse effects on the animals. Herbal drugs used in human practice 
are often utilized in pets, in particular by owners who use such remedies for 
themselves. They are given to companion animals to treat respiratory, skin, 
urinary, digestive, and cardiovascular affections, and to reduce stress; 
moreover, they are also used to treat some chronic diseases instead of 
conventional drugs in order to avoid adverse effects that sometimes could 
occur as a consequence of a prolonged administration of synthetic drugs. 
Finally, phytotherapy could represent a useful support to conventional 
therapies in the case of severe illness (Severino and Ambrosio, 2012). 
I.II.I Medicinal Plants Used in Veterinary Practice as Antibacterial 
Many hundreds of plants worldwide are used in traditional medicine as 
treatments for bacterial infections. Some of these have also been subjected 
to in vitro screening but the efficacy of such herbal medicines has seldom 
been rigorously tested in controlled clinical trials. Conventional drugs 
usually provide effective antibiotic therapy for bacterial infections but there 
is an increasing problem of antibiotic resistance and a continuing need for 
new solutions. For these reasons, many researchers have attempted to find 
natural compounds to replace antibiotics to treat bacterial infections. While 
few studies have been carried out to evaluate the therapeutic efficacy of 
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herbal remedies in companion animals, many studies have been reported in 
the literature relating to the use of plants and plant materials in farm 
animals. 
Several research articles focus on the potential antibacterial activity of 
medicinal plants used in ethnoveterinary medicine. Luseba et al. (2007) 
tested dichloromethane extracts for antibacterial and anti-inflammatory 
activity in a study appraising the efficacy of South African medicinal plants 
used in the treatment of wounds and retained placenta in livestock. Cissus 
quadrangularis L. (Vitaceae) stem and Jatropha zeyheri Sond. 
(Euphorbiaceae) root extracts showed anti-inflammatory activity against 
cyclooxygenase-2 enzyme. The extracts tested were not mutagenic in the 
Ames test against Salmonella typhimurium strain TA98. 
The antibacterial activity of essential oils derived from plants such as Salvia 
spp. (Lamiaceae) and clove has been demonstrated against many 
microorganisms such as Brucella, Salmonella typhimurium, E. coli, Bacillus 
cereus and Staphylococcus aureus in several in vitro studies (Bouaziz et al., 
2009; Burt, 2004; Horiuchi et al., 2007; Lans et al., 2009; Motamedi et al., 
2010). 
Intestinal nematodes are extremely important pathogens of domestic 
livestock, especially sheep, goats and cattle. Collectively, they are 
responsible for severe losses to livestock agriculture throughout the world. 
It has been calculated that, in the U.K., intestinal worms constitute the most 
important disease-related cost of farming sheep, being responsible for an 
estimated annual loss to the industry of £83 millions (Nieuwhof and Bishop, 
2005). In developing countries, intestinal worm infestations are perceived 
to be the single most important threat to economic success, as was made 
dramatically clear in a recent review of the attitudes and concerns of small 
hold farmers in Africa (Perry, 2002). 
Intestinal nematodes are also important pathogens of humans, with a range 
of pathologies and consequences for human health (Bethony et al., 2006); 
four species dominate: Ascaris lumbricoides, Trichuris trichiura and two 
hookworms Ancylostoma duodenale and Necator americanus (Bethony et 
al., 2006; Horton, 2003). 
The treatment of intestinal nematode infestations in the 21st century is 
carried out using modern synthetic anthelmintics. Three classes of these 
anthelmintics dominate the market, each mediating the effect through a 
different mode of action on the target nematodes: 
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the benzimidazoles, the nicotinic aceticoline agonist such as pyrantel, 
levamisole, morantel and the macrocyclic lactones. 
Although there are signs that novel synthetic drugs are being developed 
(e.g., nitazoxanide, cyclic depsipeptides, octadepsipeptides such as 
emodepside, tribendimidine, diketopiperazines such as paraherquamides, 
amino-acetonitrile derivatives), no new anthelmintic drugs have become 
available on the market for the treatment of either livestock or human 
parasitosis (Cappello et al., 2006; Geary et al., 1999; Harder et al., 2005; 
Xiao et al., 2005). Different studies have shown that some plant extracts 
effectively reduce parasite infestation in sheep and are promising 
alternatives to conventional anthelmintics (Githiori et al., 2006). An 
alternative to synthetic drugs is to exploit plant-occurring compounds. 
Medicinal plants and fruits have been used by indigenous people for 
centuries as sources of extracts used in the treatment of a variety of 
disorders, including infectious diseases and those caused by parasites, in 
livestock and humans (Hammond et al., 1997; Mueller and Mechler, 2005; 
Waller et al., 2001). These are often referred to as ethno-veterinary or ethno-
medical remedies, and, in general, they are shunned by traditional, 
conventional western medicine (Behnke et al., 2008). 
The use of ethnoveterinary plant preparations has been documented in 
different parts of the world (Anon, 1996; Bizimana, 1994; Waller et al., 
2001; Wanyama, 1997). In many developing countries, farmers, herders, 
pastoralists and occasionally veterinary surgeons use plant or plant products 
to treat cases of parasitism. The related available evidence mainly concerns 
gastrointestinal helminths, but there is also evidence for effects on blood 
parasites and external parasites. In traditional societies, a number of plant 
remedies are described as suitable for each parasitic disease (Githiori et al., 
2006). Some of the earliest known medicinal anthelmintic plants include 
Carica papaya L. (Caricaceae), Ficus spp. (Moraceae) and Ananas comosus 
(L.) Merr. (Bromeliaceae). Indeed, European doctors used papain and 
papaya latex for the treatment of worms in the 19th century (Jonxis and 
Bekins 1953, Stransky and Reyes 1955). The active components of this 
plant preparations are now known to be cysteines proteinases (CP) that 
occur naturally in various part of the plants. 
Despite evidence of anti-parasitic properties of several plants or plant 
products, there is still a need to provide validated experimental data of 
biologically meaningful reductions in infestation levels to support the view 
that plants may play a direct role in the sustainable control of helminth 
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infestations in farming situations. Plant products that have shown high 
activity against nematode parasites in vitro need to be evaluated and tested 
in ruminant hosts. However, plants with moderate anthelmintic activity 
should still be considered; may be not as a unique alternative to anthelmintic 
drugs, but as part of an integrated approach specifically designed to achieve 
sustainable parasite control in a livestock production systems. 
I.III Plant molecules for drug discovery 
Plant compounds have been the source of inspiration for chemists and 
physicians for millennia, representing the richest font of novel compound 
classes and an essential wellspring of drugs and drug leads. According to 
Newman and Cragg (2016) 62% of the 1142 small-molecule introduced as 
drugs worldwide during 1981–2014 can be traced to or were inspired by 
natural products (Fig. 2). These include natural products (4%), natural 
product derivatives (21%), synthetic compounds with natural-product-
derived pharmacophores (4%), and synthetic compounds designed on the 
basis of knowledge gained from a natural product (that is, a natural product 
mimic; 11%). In some therapeutic areas, the output is higher: 73% of 
antibacterials and 72% of anticancer compounds are natural products or 
have been derived from, or inspired by, a natural product. 
 
 
 
Fig. 2 All new approved drugs 1981−2014; n = 1562. (adopted by Newnan et al 2016) 
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These numbers are not surprising since it is known that natural products 
evolved for self-defense. Despite that record of productivity, natural 
products for drug discovery was de-emphasized in many big pharmaceutical 
companies in 1990s when combinatorial chemistry had place, and the 
reasons were primarily practical. But after several years was clear that 
database of natural products has a major number of unused scaffolds, and 
couldn’t be discarded as starting points for new drugs discovery. The 
differences between synthetic compounds and natural products are 
remarkable, especially in their structural properties (Rosén et al., 2009). On 
average, natural products have higher molecular weights; incorporate fewer 
nitrogen, halogen, or sulfur atoms, but more oxygen atoms and are sterically 
more complex, with more bridgehead tetrahedral carbon atoms, rings, and 
chiral centers. This gives them a high “sterical complexity” due to the fact 
that the enzymes used for biosynthesis, as well as their molecular targets, 
are inherently three-dimensional and chiral. Furthermore, nature has a 
limited palette of building blocks at its disposal, and thus has to generate 
novelty by branching out common intermediates into different scaffolds 
(Lahlou, 2013). 
HTS HITS LEADS CANDIDATES
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Fig. 3 The current lead discovery process 
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AIM OF THE PROJECT 
The purpose of this project has been the identification of plant derivatives 
with biological activity mainly for veterinary use. 
Accordingly, to this, the research project has been mainly focused on the 
following objectives:  
• to validate the therapeutical properties of plants used in the 
traditional for both human and veterinary use; 
• to isolate the compounds responsible for the biological activity; 
• to individuate new natural bioactive compounds as leads for the 
design of new drugs; 
• to search plants secondary metabolites with antiparasitic and 
antimicrobial activity. 
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1.1 Asteraceae family 
 
The plant family of Asteraceae is distributed worldwide except for 
Antarctica. The Asteraceae (Compositae) with its approximately 12 
subfamilies, 43 tribes, over 1,620 genera and more than 23,600 species is 
the largest family of flowering plants (Stevens, 2001). Among these, several 
plants exhibit economic, medicinal, ornamental and food importance. 
Moreover plants belonging to this family are important sources of 
biologically active compounds, and they synthesize different classes of 
specialized metabolites such as flavonoids, phenylpropanoids, 
sesquitertenoids, diterpenoids, triterpenoids and a large variety of 
glycosides. (Yaoita et al., 2012). Particularly, the Asteraceae are rich in 
sesquiterpene lactones, it is reported that these compounds inhibit tumor 
growth by selective alkylation of biomolecules which control cell division, 
thereby inhibiting a variety of cellular functions hence directing the cell into 
apoptosis. (Chaturvedi, 2011). 
 
1.2 Psiadia genus 
 
Psiadia genus includes about 60 species around the world (Oliver, 1916). 
Many plants belonging to the Psiadia genus are used in folk medicine in 
many countries. Psiadia ssp are used in traditional African medicine as 
infusion for the treatment of various disorders such as abdominal pain, fever 
and flu, or as an expectorant for asthma and bronchitis (Kokwaro et al., 
1976). In Mauritius Islands, several Psiadia ssp. are traditionally used as 
infusion for the treatment of pulmonary infections, inflammatory diseases, 
small wounds and burns (Gurib-Fakim & Gueho, 1995 (Li et al., 2013). 
During the last years, several plants of the Psiadia genus have been 
investigated for their high chemical diversity, and interesting biological 
activities. The secondary metabolites most frequently isolated in Psiadia 
ssp. are tetracyclic diterpenes, and highly oxygenated and metoxylated 
flavonoids. Some of the most characteristic flavonoids and diterpenoids of 
Psiadia genus are briefly reported below. 
1.2.1 Flavonoids 
Flavonoids are nearly ubiquitous in plants and are recognized as the 
pigments responsible for the colours of leaves. Due to their chemical 
structure, flavonoids are largely known and used as antioxidant although 
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many biologically activities have been reported for these natural compounds 
such as anti-inflammatory, antiproliferative, antitumoral, antimicrobial 
(Middleton et al., 2000). 
A large number of flavonoids has been discovered in different species of 
Psiadia such as P.altissima, P. trinervia, P.dentata and P.arabica. The 
biological activities reported for Psiadia flavonoids are antimicrobial and 
antioxidant activity. The flavonoids isolated from the genus Psiadia are 
shown in Fig. 1.1 (Canonica et al., 1967; El-Feraly et al., 1990; Jakobsen et 
al., 2001; Mossa et al., 1992a; Wang et al., 1989). 
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Fig. 1.1. Flavonoids in Psiadia genus 
 
1.2.2 Diterpenoids 
Diterpenoids are a vast class of natural products, biosynthesized from 
mevalonic acid through 2E,6E,10E-geranylgeranyl pyrophosphate 
(GGPP). 
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Different biological activities have been described for diterpenes and their 
derivatives, including plant growth regulating, antimicrobial, antiparasitic, 
insect antifeedant, cytotoxic, antitumor, anti-HIV, antifertility, hypotensive 
and antiinflamatory activities, (García et al., 2007). The most important 
diterpenoids isolated from the genus Psiadia particularly P. altissima (DC.) 
Drake and P. arabica DC. are shown in Fig. 1.2 (Canonica et al.,1967, and 
El-Domiaty et al. 1993. 
    
Fig. 1.2 Diterpenoids of Psiadia genus 
1.3 Psiadia punctulata (DC.) Vatke 
Psiadia punctulata (DC) Vatke also known as, Psiadia aparine mosses, 
Psiadia resiniflua, Baccharis resiniflua is an African species gradually 
worldwide diffused. In Saudi Arabia. P. punctulata is well known in the 
antique Arabic medicine, it is called “Tobbag”, this plant grows in the 
mountains surrounding by the Holy Makkah, it produces high amount of leaf 
exudate. The leaves exudate of P. punctulata is produced systematically and 
it is more abundant during hot seasons (Gushash, 2006). In the Saudi 
ethnomedicine the leaves rich in exudate are summered in hot water then the 
oily layer is collected and preserved in a recipient to be used as wounds 
disinfectant. The leaves are also burned as insect repellant, the warmed fresh 
leaves are applied locally to accelerate the healing of broken bones in human 
and animals (Ogweno Midiwo et al., 1997). A leaves decoction is used 
locally for the treatment of cold and fever (Kokwaro, 1976) and for the 
removal of ectoparasites from cattle (Beentje, 1994). The shrub is known to 
be avoided by browsing herbivores like giraffes and goats, even during 
severe drought. 
1.3.1 Previous phytochemical studies on Psiadia punctulata (DC) Vatke 
Previous phytochemical studies of leaves exudate reveal the presence of 
different class of metabolites including diterpenes, flavonoids, 
phenylpropanoids (Juma et al., 2006; Juma et al., 2001; Midiwo et al., 1997), 
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while the propolis obtained from this plant is rich in diterpenes and 
flavonoids (Almutairi et al., 2014). The main flavonoid isolated in 
P.punctulata exudate are reported in Fig. 1.3. 
 
Compounds R1 R2 R3 R4 
5 OH-6,7,8,4’-tetrametossiflavon H OCH3 H H 
5 OH-3,6,7,4’-tetrametossiflavon OCH3 H H H 
5,3’ OH-6,7,4’,5’-tetrametossiflavon H H OH OCH3 
5,3’ OH-6,7,8,4’,5’-pentametossiflavon H OCH3 OH OCH3 
5 OH-6,7,3’,4’,5’-pentametossiflavon H H OCH3 OCH3 
 
Compounds R1 R2 R3 R4 
Chrysoeriol H OH OCH3 OH 
Cirsilineol OCH3 OCH3 OCH3 OH 
Luteolin H OH OH OH 
Acacetin H OH H OCH3 
Apigenin H OH H OH 
 
Compounds R1 R2 R3 
5,7- OH-2’,3’,4’,5’-tetrametossiﬂavon H CH3 CH3 
5- OH-7,2’,3’,4’,5’-pentametossiﬂavon CH3 CH3 CH3 
5,4’- OH-7,2’,3’,5’-tetrametossiﬂavon CH3 CH3 H 
5,7,4’- OH-2’,3’,5’-trimetossiflavon H CH3 H 
5,7,3’- OH-2’,4’,5’-trimetossiflavon H H CH3 
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Compounds R1 R2 R3 
Cynaroside H O-Glu H 
Orientin H OH O-Glu 
Iso orientin O-Glu OH H 
Fig. 1.3 Flavonoids of P. punctulata 
The diterpenoids obtained from the P. punctulata exudate are shown in Fig. 
1.4. 
 
Compounds R1   
(ent)-Kaur-16-en-2α,18,19-triol OH   
(ent)-2-oxokaur-16-en-18,19-diolo =O   
 
Compounds R1 R2  
Trachyloban-2β,6β, 19-triol OH CH3  
2-oxotrachyloban-18,19-diol =O CH3  
6α,17,19-ent-Trachylobantriol H2 CH2OH  
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Compounds R1 R2  
2α,18,19-ent-Trachylobantriol OH H  
2β,6α,18,19-ent-Trachylobantetraol OH OH  
 
 
(ent)-16β,17-Dihydroxykaur-20-oic acid 
 
ciliaric acid 
Fig. 1.4 Kaurane and trachylobane diterpenes of P. punctulata exudate 
1.3.2 P. punctulata biological activities 
Studies reported the biological properties of Psiadia punctulata. Midiwo et 
al. (2002) highlighted the pesticides effects of the leaves exudate against 
Locusta migratoria, and the antifungal activity against Colletotricum 
coffeanum and Fusarium ossisporum respectively fungi that infest coffee 
and potatoes. Several authors reported the antiprotozoal activity of the bark 
of P punctulata against Leishmania major (Mothana et al., 2011). 
The methanol extract of P. punctulata whole plant was in vivo tested in order 
to investigate Its pharmacological activities. The results showed a blood 
pressure lowering and the phrenic neuromuscular nerve blocking. The same 
extract was also test on unstriated muscle of mice trachea showing relaxant 
properties. Furthermore, methanol extract of P. punctulata was 
demonstrated to induce contraction of mean intestine in rabbit; this 
pharmacological activity could be compared to effect of Verapamil and may 
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be due to interference with the depolarization processes linked to the 
operation of the voltage-gated calcium channels (Achola et al., 1998). 
1.3.3 Antimicrobial activity 
In recent years, there have been concerns about increased frequencies of 
antibiotic resistance among bacteria found in food animals and in the 
environment (Jensen et al., 2001). In fact, the extensive use of antibiotics in 
animal practice for therapy are considered to be the major reasons for the 
development of bacterial resistance to antibiotics (Barton, 2000; Sengeløv 
et al., 2003). Antibiotics are used continuously as feed additives at sub-
therapeutic levels to promote growth to increase feed efficiency and to 
prevent infection and (Jindal et al., 2006; Wegener, 2003). 
Presently, there is a growing interest in natural antibacterial derivatives such 
as extracts of spice and herb for both food preservation and for the 
development of new antibacterial compounds. Natural compounds could be 
an alternative source of novel therapeutics, the relatively low frequency of 
infectious diseases in wild plants suggests that in many cases these natural 
defence mechanisms can be very effective, than many plants are 
investigated for their potential and antimicrobial activity (Hemaiswarya et 
al., 2008; Shan et al., 2007). Staphylococcus aureus is a major opportunistic 
pathogen in humans and one of the most important pathogenic 
Staphylococcus species in veterinary medicine. S. aureus is dangerous 
because of its deleterious effects on animal health and its potential for 
transmission from animals to humans and vice-versa. It thus has a huge 
impact on animal health and welfare and causes major economic losses in 
livestock production (Holmes and Zadoks, 2011). S. aureus is a saprophyte 
of mucous membranes and the skin of man and other mammals. It’s able to 
colonize the udder of milk producing animals (cows, sheep, goats) and also 
is the most frequently responsible for food poisoning species, is one of the 
most feared bacteria, because of Its multidrug-resistant strains to antibiotics 
(Peton and Le Loir, 2014). The study of Gouda et al. (2014) showed that the 
methanol extract of P. punctulata whole plant exhibited a significant 
antibacterial activity against the Gram-positive S. aureus 25913 and 
antifungal activity against Candida albicans ATCC 10231. 
Moreover, in the study of Mothana et al. (2011) was investigated the 
antibacterial activity of the methanolic and water extracts from P. 
punctulata whole plant against Staphylococcus aureus ATCC 6538; Bacillus 
subtilis ATCC 6059; Micrococcus flavus SBUG 16; Escherichia coli ATCC 
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11229; Pseudomonas aeruginosa ATCC 27853; Candida maltosa SBUG; 
multiresistant Staphylococcus epidermidis 847; multiresistant 
Staphylococcus haemolyticus 535; multiresistant Staphylococcus aureus 
NGR. The result showed that the methanolic extract was more effective than 
the water extract, as displayed by the respective inhibition diameters against 
the following microbial strain: Staphylococcus aureus ATCC 6538 (14mm 
and 11mm); Bacillus subtilis ATCC 6059 (12mm and 0mm); Micrococcus 
flavus SBUG 16 (22mm and 14 mm); multiresistant Staphylococcus 
epidermidis 847 (20 mm and 15 mm); multiresistant Staphylococcus 
haemolyticus 535 (12 mm and 0 mm); multiresistant Staphylococcus aureus 
NGR (20 mm and 16 mm). On the other hand, no activity was observed 
against Escherichia coli ATCC 11229; Pseudomonas aeruginosa ATCC 
27853; Candida maltosa SBUG. 
 
AIM 
In the present work, the composition of the Psiadia punctulata surface 
secondary metabolites and the antimicrobial activities of the surface extract, 
crude fractions and pure compounds were investigated. 
 
1.4 Experimental  
1.4.1 Plant material 
The exudate obtained from the leaves (400g) of P. punctulata was collected 
in Wadi Ghazal, Saudi Arabia, in June 2012. The leaves of the plant were 
identified by Dr. Ammar Bader. A voucher specimen (SA/IT 2013/1) was 
deposited in the Laboratory of Pharmacognosy at Umm Al-Qura University, 
Saudi Arabia. 
1.4.2 Extraction and isolation 
The exudate of P. punctulata (10.0 g) was obtained from the leaves (400g) 
by dipping into dichloromethane for less than 30 seconds and it was dried at 
40 °C. Part of exudate (5.0 g) was dissolved in chloroform and separated on 
silica gel column, eluted with step gradients of CHCl3-MeOH (100:0, 
90:10,80:20, 70:30, 50:50 and 0:100). Fractions of 25 mL were collected, 
pointed and sprayed with a solution of Ce2(SO4)2/H2SO4, 65% on TLC 
plates and lastly grouped into nine main fractions (A-I) Fig. 1.5. 
Chapter 1 Psiadia punctulata (DC.) Vatke (Asteraceae) 
 
45 
Exudate of P. punctulata 
5g
S
ilic
a
l g
e
l
C
C
E
585.0 mg
C
653.4 mg
A
224.1 mg
I
577.1 mg
G
587.6 mg
F
596.0 mg
B
32.2 mg
H
351.0 mg
D
508.0 mg
 
Fig. 1.5 Separation scheme exudate of P. punctulata exudate 
Fraction C (653 mg) and D (508.0 mg) were purified by semi-preparative 
reversed phase HPLC (MeOH-H2O, 65:35) to yield pure 1 (2.2 mg, tR 6 
min), 2 (4.3 mg, tR 9.5 min), 3 (7 mg, tR 14 min), 4 (1.9 mg, tR 15.5 min), 5 
(2.2 mg, tR 18 min) 6 (1.2 mg, tR 32 min) and 7 (1.4 mg, tR 36 min) from 
fraction C, and 8 (4.3 mg, tR 8 min), 9 (3.7 mg, tR 11 min), 10 (4.9 mg, tR 13 
min), 11 (2.7 mg, tR 15 min) 12 (1.2 mg, tR 17 min) and 13 (1.2 mg, tR 20.5 
min) from fraction D. Fraction E (585.0 mg) was subjected to RP-HPLC 
(MeOH-H2O, 55:45) to give pure compounds 14 (1.0 mg, tR 14.5 min), 15 
(5.3 mg, tR 22.5 min) 16 (4.1 mg, tR 32 min) 17 (1.6 mg, tR 36 min) and 18 
(1.1 mg, tR 40 min). Fraction F (596.3 mg) was subjected to RP-HPLC 
(MeOH-H2O, 1:1) to give pure compounds 19 (1.8 mg, tR 5 min), 20 (1.0 
mg, tR 7.5 min) and 21 (1.5 mg, tR 41 min). Fraction G (587.0 mg) was 
separated to RP-HPLC (MeOH-H2O, 55:45) to yield pure compounds 22 
(1.3 mg, tR 16 min), 23 (1.5 mg, tR  27.5 min), 24 (1.7 mg, tR 36.5 min) 25 
(1.1 mg, tR 57.0 min)  and 26 (2.3 mg, tR 62.5 min). Fraction H (351.0 mg) 
was subjected to RP-HPLC (MeOH-H2O, 1:1) to give pure compounds 27 
(1.0 mg, tR 3 min), 28 (3.5 mg, tR 35 min), 23 (0.6 mg, tR 45 min) 29 (7.5 
mg, tR 60 min) and 24 (1.5 mg, tR 60 min), 30 (1.7mg, tr 12min). 
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1.4.2.1 Compound 10 
White substance;  25D : -152.6° (c 0.26, CH3OH); for 
1H and 13C NMR 
spectroscopic data, see Tab. 1.6; HRESIMS m/z: 319,2267 [M+H]+, calcd. 
for C20H30O3, 318.2195. 
1.4.2.2 Compound 14 
Amorphous white powder;  25D : -22.3° (c 0.06, CH3OH); for 
1H and 13C 
NMR spectroscopic data, see Tab. 1.3; HRESIMS m/z: 323.2581 [M+H]+, 
calcd. for C20H34O3, 322.2508. 
1.4.2.3 Compound 18 
White substance;  25D : -67.5° (c 0.04, CH3OH); for 
1H and 13C NMR 
spectroscopic data, see Tab. 1.6; HRESIMS m/z: 321.2422 [M+H]+, calcd 
for C20H32O3, 320.2351. 
1.4.2.4 Compound 19 
White substance;  25D : -109.3° (c 0.15, CH3OH); for 
1H and 13C NMR 
spectroscopic data, see Tab. 1.7. HRESIMS m/z: 335.2215 [M+H]+, calcd 
for C20H30O4, 334.2144. 
1.4.2.5 Compound 20 
White substance;  25D : -65.8° (c 0.08, CH3OH); for 
1H and 13C NMR 
spectroscopic data, see Tab. 1.7. HRESIMS m/z: 335.2216 [M+H]+, calcd. 
for C20H30O4, 334.2144. 
1.4.2.6 Compound 21 
Amorphous white powder;  25D : -85.2° (c 0.14, CH3OH); for 
1H and 13C 
NMR spectroscopic data, see Tab. 1.4. HRESIMS m/z: 321.2422 [M+H]+, 
calcd for C20H32O3, 320.2351. 
1.4.2.7 Compound 22 
White substance;  25D : -20.9° (c 0.07, CH3OH); for 
1H and 13C NMR 
spectroscopic data, see Tab. 1.8. HRESIMS m/z: 337.2371 [M+H]+, calcd 
for C20H32O4, 336.2301. 
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1.4.2.8 Compound 23 
Amorphous white powder;  25D : -123.7° (c 0.13, CH3OH); for 
1H and 13C 
NMR spectroscopic data, see Tab. 1.4. HRESIMS m/z: 337.2373 [M+H]+, 
calcd for C20H32O4, 336.2301. 
1.4.2.9 Compound 24 
White oil-like substance;  25D : -75.0° (c 0.14, CH3OH); for 
1H and 13C 
NMR spectroscopic data, see Tab. 1.8. HRESIMS m/z: 335.2218 [M+H]+, 
calcd. for C20H30O4, 334.2144. 
1.4.2.10 Compound 25 
Amorphous white powder;  25D : -18.1° (c 0.06, CH3OH); for 
1H and 13C 
NMR spectroscopic data, see Tab. 1.5. HRESIMS m/z: 323.2580 [M+H]+, 
calcd. for C20H34O3, 322.2508. 
1.4.2.11 Compound 27 
Amorphous white powder;  25D : -77.9° (c 0.04, CH3OH); for 
1H and 13C 
NMR spectroscopic data, see Tab. 1.5. HRESIMS m/z: 353.2331 [M+H]+, 
calcd for C20H32O5, 352.2250. 
1.4.2.12 Compound 28 
Amorphous white powder;  25D : -62.9° (c 0.17, CH3OH); for 
1H and 13C 
NMR spectroscopic data, see Tab. 1.5. HRESIMS m/z: 339.2528 [M+H]+, 
calcd for C20H34O4, 338.2457. 
1.4.2.13 Compound 30 
Amorphous white powder;  25D : -57.0°; for 
1H and 13C NMR spectroscopic 
data, see Tab. 1.3. HRESIMS m/z: 339.2531 [M+H]+, calcd. for C20H34O4, 
338.2457. 
1.4.3 In vitro antimicrobial activity 
The in vitro minimal inhibitory concentrations (MICs) against Candida 
albicans (ATCC MYA-2876) strains was determined by the micro-broth 
dilution method in 96-well plates according to the guidelines suggested by 
the CLSI document M27-A3 (Clinical and Laboratory Standards Institute. 
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Reference Method for Broth Dilution Antifungal Susceptibility Testing of 
Yeasts—Third Edition: Approved Standard M27-A3. CLSI, Wayne, PA, 
USA, 2008.). Colonies from Sabouraud's dextrose agar plate were 
inoculated into prewarmed RPMI 1640 medium (with l-glutamine, 2% 
glucose, without bicarbonate, and with phenol red as a pH indicator) 
buffered to pH 7.0 with 0.165M morpholine propane sulfunic acid (MOPS). 
Two-fold serial dilutions of extract (concentrations ranging from 10 to 640 
ug/ml) or fractions (concentrations ranging from 6.25 to 200 ug/ml) were 
added to each well containing 2 × 103 yeast/ml. After 24 and 48 h of 
incubation at 37°C growth was measured by reading the absorbance with a 
microplate reader (Lab-system Multiskan EX 51118171, Thermo Scientific, 
Milan, Italy) at 530 nm. MIC2 were recorded as lowest concentrations of 
extract or fraction that resulted in 50% decrease in absorbance compared to 
the control (cells containing only medium and vehicle). 
Similarly, the antibacterial activity of extract and fractions were tested 
against Staphylococcus aureus and Pseudomonas aeruginosa. The MICs 
were carried out in Mueller-Hinton broth (MHB) by microdilution method 
using 96-well microtiter plates according to the Clinical and Laboratory 
Standards Institute (CLSI) guideline (CLSI 2008. Performance standards for 
antimicrobial susceptibility testing: 18th informational supplement. CLSI 
document. Wayne, PA: Clinical Laboratories Standards Institute, pp. 46–
52). Briefly, bacteria were grown o.n. in MHB medium at 37°C. Cultures 
were then diluted to approximately 106 CFU/mL in fresh MHB medium, and 
200 μL was used to inoculate flat-bottom 96-well polystyrene microtiter 
plate. Different concentration of extract concentrations ranging from 10 to 
640 ug/ml) and fractions (concentrations ranging from 6.25 to 200 ug/ml) 
were added in each well, and after incubation o.n. at 37°C, cells absorbance 
was measured at 595 nm using a microplate spectrophotometer. Cells treated 
with only vehicle were used as control.  
1.4.3.1 Biofilm formation 
In order to determine the capacity of fractions to inhibit the biofilm 
formation of Candida, yeast cells were inoculated into 7ml of Yeast 
Nitrogen Base (YNB) with 100 mM glucose (pH 7.0) and incubated 
overnight at 25 °C. Using the McFarland Tab., appropriate dilutions of the 
o.n. cultures were carried out in order to obtain 107 cells/mL. Culture was 
aliquoted in a 96-wells flat bottom plate (0.2 ml/well). The Candida cells 
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were allowed to adhere for 90 min at 37 °C, afterwards, wells were washed 
with phosphate buffered saline (PBS, pH 7.2) to remove Candida non 
adherent cells. To allow the adherent yeast cells to germinate and eventually 
to form biofilms, new YNB medium pH 7.0 with different concentrations of 
fractions 2, 3, 8 and 27 (40, 60, 80 and 100 ug/ml) were added to each well 
and incubated at 37 °C. After 48 hours the biofilm mass was washed with 
PBS, dried and stained with crystal violet (CV, 0.3% (w/v) for 15 min. After 
rinsing with water, to quantify the biofilm mass, the CV was solubilized 
with 200 μL of acetic acid (33% v/v), and absorbance was measured at 
595nm using a spectrophotometer. 
A similar protocol was used to analyse the effect of fractions 2, 3, 8 and 27 
(40, 60, 80 and 100 ug/ml) on Staphylococcus biofilm formation. Briefly, 
the culture supernatant was discarded, and the wells were washed twice with 
PBS to remove loosely adherent cells and then stained for 1 min with 200 
μL of CV. The wells were then rinsed with water and dried. The amount of 
biofilm biomass was quantified by destaining wells with 200 μL of 33% 
acetic acid and then measuring the absorbance of the CV solution in a 
microplate spectrophotometer set at 595 nm. Cells treated with only vehicle 
were used as control.  
Each antimicrobial assay was performed in triplicate in separate days. 
1.5 Results and Discussions 
The antimicrobial activity of the dichloromethane extract was tested against 
a Gram-positive (Staphylococcus aureus), a Gram-negative bacteria 
(Pseudomonas aeruginosa), and the dimorphic fungi Candida albicans, 
causal agent of opportunistic oral and genital infections in humans. The 
results showed an antibacterial activity of the extract against S. aureus 
(MIC50= 100 μg/mL) while no activity was detected against the Gram-
negative bacteria. Moreover, the extract showed an antifungal activity 
aganinst C. albicans, with MIC2= 50 μg/mL and  MIC0= 130 μg/mL. 
The extract was subsequently separated by column chromatography on 
silica gel, collecting nine fractions A-I. Fractions were evaluated for their 
antimicrobial activity at the doses (from 20 to 100 µg/ml). Of the 9 fractions 
analyzed, fractions A, B and I were inactive on all the species tested while 
6 fractions (C-H) were active on the Gram-positive and on Candida albigans 
but not on the Gram-negative strain (Tab. 1.1 and Fig. 1.6). 
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Tab. 1.1 Fractions (A-I) antimicrobial activity  
 MIC (μg/mL) 
 Antibacterial activity Antifungal activity 
Fractions 
Staphylococcus 
aureus 
Pseudomonas 
aeruginosa 
Candida albicans 
MIC50 MIC2 MIC0 
A > 200 > 200 - > 200 
B 87 > 200 20 60 
C 8 > 200 15 50 
D 18 > 200 50 100 
E 73 > 200 80 > 200 
F 62 > 200 60 100 
G 43 > 200 100 > 200 
H 65 > 200 70 90 
I > 200 > 200 80 150 
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Fig. 1.6 Antibacterial activity of fractions C (Frs C) and H (Frs H) against 
Staphylococcus aureus (STA) and Candida albigans (CA) 
The dichloromethane extract of P. punctulata active fractions were then 
separated by silica gel column chromatography and RP-HPLC to afford 
thirteen new compounds (10, 14, 18-25, 27-28, 30) along with known 
flavones (1-8 and 11) and diterpenes (9, 12-13, 15, 17, 26, 29) (Fig. 1.16). 
The flavonoids were 3',4',5-trihydroxy-6,7,8-trimethoxyflavone 
(sideritoflavone) (1) (Tomas et al., 1979b), 2',4',5-trihydroxy-6,7,5’-
trimethoxyflavone (arcapillin) (2) (Kiso et al., 1982), 3',4',5,7-
tetramethoxyflavone (3) (Joseph-Nathan et al., 1981), 4',5-dihydoxy-6,7,8-
trimethoxyflavone (xanthomicrol) (4) (Stout and Stout, 1961), 5-hydroxy-
3',4',5',6,7,8-hexamethoxyflavone (5) (gardenin A) (Rao and Venkataraman, 
1968), 4',5-dihydroxy-3',6,7,8-tetramethoxyflavone (6) (Pinkas et al., 1968), 
3',5-dihydroxy-4',5',6,7,8-pentamethoxyflavon (Gardenin C) (7) (Sujatha et 
al.,2013),5,7-dihydroxy-3′,4’-dimethoxyflavone (Luteolin 3’,4’ dimethyl 
ether) (8) (Gao and Kawabata., 2004), 4',5-dihydroxy-3',7-
dimethoxyflavone (velutin) (11) (Das et al., 1970); the diterpenes were ent-
2-oxo-kaur-16-en-6,19-diol (propsiadin) (9) (Almutairi et al., 2014), ent-2-
oxo-kaur-16-en-18,19-diol (psiadin) (12) (Almutairi et al., 2014; El-
Domiaty et al., 1993; Mossa et al., 1992b), ent-2-oxo-trachyloban-18,19-
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diol (13) (Midiwo et al., 1997), ent-2-oxo-6-hydroxy-kaur-16-en-18,19-diol 
(15) (El-Domiaty et al., 1993), ent-trachyloban-2β,6β,19-triol (16) (Midiwo 
et al., 1997), ent-trachyloban-6α,18,19- triol (17) (Juma et al., 2006), ent-
kaur-16-en-2α,18,19-triol (26) (El-Shafae and Ibrahim, 2003; Midiwo et al., 
1997), ent-trachyloban-2α,17,18-triol (29) (Juma et al., 2006), identified by 
their physical and spectroscopic data, which were largely consistent with 
those published in the literature. 
Analysis of the NMR data of compounds 14, 21, 23, 25, 27, 28, 30 suggested 
diterpenes featuring an ent-kaurane skeleton (García et al., 2007a; Kataev et 
al., 2011). This observation was confirmed by 1H-1H COSY data that 
revealed the spin systems H-1__H2-2
__H-3, H-5__H-6__H2-7and H-9
__H2-
11__H-12__H-13__H2-14 and by HMBC correlations observed from H-5 (δH 
0.80 - 1.35) to C-4, C-6, C-7, C-10, C-18, C-19, C-20, from H-9 (δH 1.07-
1.33) to C-7, C-8, C-10, C-11, C-14, C-15, C-20, from H2-7 (δH 1.20-1.69 
and 1.37-1.88) to C-5, C-6, C-8, C-14, C-15, from H2-14 (δH 1.27-1.81 and 
1.90-2.28) to C-8, C-9, C-13, C-15, C-16 and from H2-15 (δH 1.44-2.18 and 
1.31-2.20) to C-7, C-8, C-9, C14, C-16. 1D-ROESY correlations H-9β/H-
15β, H-5/H3-18, H2-15/H-16, H3-19/H3-20, H2-19 and H3-20/H2-14 provided 
stereochemical information of the ent-kaurane skeleton. 
Compound 14 (Fig. 1.7) was obtained as an amorphous white powder. Its 
molecular formula C20H34O3, equating to four double bond equivalents, was 
deduced from HRESIMS (m/z: 323.2581[M+H]+. 
The 13C NMR spectra (Tab. 1.2) revealed the presence of four methyls, 
seven methylenes, five methines of which two oxygenated and four 
quaternary carbons one oxygenated. The presence of two oxigenated 
methynes, at C-3 and C-12 (δC 79.3 and 67.7, respectively), was confirmed 
by the 1H-1H COSY and 1D-TOCSY correlations H2-1
__H2-2, H-3
__H2-2, 
H-9__H2-11, H-12
__H2-11, H-12
__H-13 and H-13__H-14 and HMBC 
correlations of H2-2/C-4, H3/C-18, H3/C-19, H3-19/C-3, C-18/H-3, H-11/C-
12, H-14/C-12. The quaternary oxygenated function was collocated at C-16 
(δC 79.0), supported by HMBC correlations H-13/C-16, H-14/C-16, H-
15/C-16, H-17/C-16. The relative configuration of the basic skeleton of 
compound 14 was elucidated to be the same with that of ent-kaurane-
3α,16α-diol (Tori et al., 1993) on the basis of the double doublets resonance 
of H-3 at δH 3.15 and by analysis of the 1D ROESY spectra: selective 
irradiation of H-3 produced significant enhancement of the proton signal at 
δH 0.79 (H-5) and 0.99 (H3-18). Furthermore, upon irradiation of H-12 (δH 
Chapter 1 Psiadia punctulata (DC.) Vatke (Asteraceae) 
 
53 
3.90) a ROE response with H-13 (δH 1.96) and H-17 (δH 1.34) was observed. 
Thus, 14 was charachterized as ent-kaurane-3α,12α,16α-triol. 
 
 
Fig. 1.7 NMR spectra of compound 14 
 
Compound 30 was obtained as a colourless powder. The positive HRESIMS 
gave a quasi-molecular ion peak at m/z 339.2531 in accordance with the 
molecular formula C20H34O4 and four indices of hydrogen deficiency. The 
NMR data Tab. 1.2 of compound 30 showed marked similarities with 
compound 14, except for resonances of an additional oxymethylene (δH 
3.58, 3.65) group and the absence of the signal for one methyl group. The 
HMBC cross-peaks of signals at ppm 3.58 (1H, d,J=13.0 Hz) and 3.65 
(1H,d,J=13.0 Hz) with C-13, C-15 and C-16 suggested that the hydroxy 
group was located at C-17. 
The 1D-ROE correlations of Me-18 with the H5/H9 indicated a β-
orientation of H-5 and H-9 and α-orientation of OH-3. The β orientation of 
CH2OH-17 was elucidated comparison of by the 
13C NMR data with those 
of literature (Liug et al.,2003). 
Thus, the structure of 30 was defined as ent-kaurane-3α,12α,16α,17-tetraol. 
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30 
Compound 21 was obtained as an amorphous white powder and it was 
assigned the molecular formula C20H32O3 by its HRESIMS m/z: 321.2422 
[M+H]+, indicating five hydrogens deficiency. 
The 1H NMR spectrum showed the presences of two methyl singlets at δH 
1.29 (Me-19) and δH 1.20 (Me-20); two oxymethines at δH 3.82 (H-2) and δH 
4.07 (H-6), one hydroxymetilene at δH 3.96 and 3.50 (H2-19) and two H-2 
olefinic protons at δH 4.80 (1H1, s) and 4.85 (1H1, s). 
COSY and 1D-TOCSY measurements showed couplings between H1__H3, 
H5__H7, H9__H14, H15__H17, led to the assignment of the molecule spin 
systems. The elucidation of the whole skeleton from the above subunits was 
achieved on the basis of HSQC and HMBC correlations which also allowed 
the assignment of the resonances of the pertinent carbons 
The 1H and 13C NMR data (Tab. 1.3) were quite similar to those reported for 
ent-2-oxo-kaur-16-en-6,19-diol (propsiadin) (Almutairi et al., 2014). The 
structure of 21 differed from propsiadin in C-2, where the oxo group was 
replaced by an oxymethine group (δC 64.3; δH 3.83 m). This was verified by 
HMBC correlations H1/C2 and H3/C2, H1/C3, H1/C2, H1/C5, H3/C1, 
H3/C2; H3/C5. 
The α-axial orientation of H-2 was inferred by its J values (tt, J(H-3ax/H-2) = 
15.6 Hz, J(H-3eq/H-2) = 5.5 Hz, J(H-1ax/H-2) = 13.6 Hz. The α-axial orientation of 
H-6 was inferred by its J values (ddd, J(H-6ax/H-5) = 13.0 Hz). The relative 
position of the substituents was confirmed by 1D-Roesy spectra. 
From the above information and literature data, the structure of compound 
21 was then elucidated as ent-kaur-16-en-2β, 6β,19-triol. 
21 
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Compound 23 was obtained as an amorphous white powder, It showed a 
molecular formula of C20H32O4, according to an [M+H]
+ ion at m/z 337.2373 
(calcd. for 336.2301) in its HRESIMS, indicative of five indices of hydrogen 
deficiency.  
The 1H and 13C NMR data of 23 (Tab. 1.3) indicated the presence of two 
hydroxymethylenes and two hydroximethine groups moreover, an exo-
methylene group was clearly evident in 1H NMR spectrum (2 H, br s at δH 
4.35 and 4.38). The NMR spectral data combined with 1D-TOCSY and 
COSY suggested the sequences H1__H3, H5__H7, H9__H14, H15__H17. 
The 1H and 13C NMR data of 23 showed a high degree of similarity with 
compound 21. The signals, in the NMR spectrum of 23, at δH 3.62 d (J=11.0 
Hz), 4.03 (overlapped signal) and δC 65.4 suggested the presence of an 
additional oxymethyl group, this was located at C-18 on the basis of 
chemical shift and HMBC correlations H2-3/C-18, H-5/C-18, H2-18/C-19, 
H2-19/C-18 and H2-18/C-4 Therefore, the structure of 23 was identified as 
ent-kaur-16(17)-en-2β,6β,18,19-tetraol. 
23 
Compound 27, obtained as a white powder, gave a molecular formula of 
C20H32O5 according to a [M+H]
+ ion at m/z 353.2331 its HRESIMS 
requiring five degrees of unsaturation. The 1H and 13C NMR (Tab. 1.4) 
features of 27 were closely related to those of ent-16α-17,19-trihydroxy-
kauran-2-one (Chen et al., 2010). The difference between the compounds 
was that the methilene moiety at position 6 in ent-16α-17,19-trihydroxy-
kauran-2-one this was replaced by an oxymethine in 27. This assignment 
was confirmed by the downfield shifting of C-6 [δC 68.7; δH 4.04 br d (J=3.9 
Hz)], C-5 (59.2 ppm) and C-7 (51.3 ppm) and an upfield shift of C4 (42.9 
ppm) and by the 1D-TOCSY spectrum showing H-5__H-6__H2-7 spin 
system. The β OH-6 was defined by the observation of the H-6 coupling 
constant [δH 4.04 br d (J = 3.9)], typical of an  axial proton. The 1D ROESY 
confirmed the relative configuration. 
Accordingly, compound 27 was identified as ent-kaur-6β,16α,17,19-
tetrahydroxy-2-one. 
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27 
Compound 28 (Fig. 1.8) was isolated as an amorphous white powder. Its 
molecular formula was determined as C20H34O4 by the positive HRESIMS 
at m/z 339.2528, and accounted for four degrees of unsaturation. 
The 1H and NMR spectrum (Tab. 1.4) showed signals for two tertiary methyl 
groups, two pair doublets centred at δH 4.01, 4.03, 3.60, 3.46 for two 
hydroxymethylenes groups and one hydroxymethine at δH 4.01. 
The 13C NMR spectra showed the presence of two methyls, 8 methylenes, 
two hydroxymethylenes, three methynes, one hydrowxymethine and four 
quaternary carbons, group, one hydroxymethin group; it showed a good 
agreement with a kaurene derivative (Fraga et al., 2011). 
The 1H and 13C NMR spectra of 28 were nearly superimposable with those 
of 27, with the exception of the lacking of the signal of the keto group at 
position 2, replaced by a methylene [δC 19.4; δH 1.45 and 1.62]. The 1D-
TOCSY showed the spin system H-1__H-3. 1H-13C long-range correlations 
from the HMBC experiment of H2-1 and of H2-3 to the signal at ppm 19.4 
confirmed the attribution. 
Compound 28 was then established as ent-kaur-6β,16α,17,19-tetraol. 
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Fig. 1.8 NMR spectra of compound 28 
Compound 25 was obtained as an amorphous white powder. Its HRESIMS 
spectrum exhibited a quasimolecular ion [M+H]+ peak at m/z: 323.2580 
(calcd. for 322.2508) in accordance with the molecular formula C20H34O3, 
and requiring four degrees of unsaturation. Comparison of the 1H and 13C 
NMR data of 25 (Tab. 1.4) with those of ent-Kaurane-2α,16β,18-triol 
(Tanaka et al., 1978), indicated that both compounds had similar skeleton 
and substitution pattern. The only exception was the β orientation of H-2, 
showed by compound 25, supported by coupling constants of H-1eq [δH 1.38 
br dd (J = 13.9, 1.5)] and H-1ax [δH 1.67 dd (13.9, 4.7)]. 
Therefore, compound 25 was determined to be ent-kaurane-2β,16,18-triol. 
25 
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Compound 18 (Fig. 1.9) was obtained as white substance. Its molecular 
formula C20H32O3 was established by its HRESIMS data (m/z: 321.2422 
[M+H]+). This implied five indices of hydrogen deficiency. Compound 18 
was assigned a ent-trachylobane skeleton by comparison of their 
spectroscopic and physical data with those reported in the literature (Amone 
et al., 1979; Fraga, 1994; Juma et al., 2006; Midiwo et al., 1997). 
Particularly, the two high field resonances at δH 0.63 (H-12) and 0.89 (H-
13), observed in 1H NMR spectrum of compound 18 that indicated the 
presence of the cyclopropane ring, characteristic of the trachylobane 
structures with the methyl group at C-16 (Fraga, 1994). Analysis of 1H NMR 
spectrum showed the presence of two hydroxymethynes at δH 3.94 (1H, m), 
3.96 (1H, br dd J=11.2 and 3.2 Hz) at δH 3.34 and 4.03 (1H, d, J=10.9). 
The 13C NMR spectrum showed the presence of twenty carbons of which 3 
were oxygenated. The analysis of DQF-COSY and 1D-TOCSY let to 
establish for compound 18 the following spin systems: H-1__H-3, H5__H7, 
H9__H14. The resonances of all carbons were assigned on the basis of study 
combination of HSQC, COSY and HMBC spectra. 
NMR spectral data (Tab. 1.5) indicated that the NMR data of 18 were very 
similar to trachyloban-2β,6β,19-triol (16) (Midiwo et al., 1997). However, 
differences in the chemical shifts at position 1, [16: δH 0.73 and 1.85 vs 18: 
δH 1.22 and 1.44], 2 [16: δH 3.74 vs 18: δH 3.95] and 3 [16: δH 1.87 and 1.02 
vs 18: δH 1.55 and 1.30] suggested an α orientarion for the hydroxyl group. 
This fact was also supported by 1D ROESY NMR selective experiments. In 
these, the selective irradiation of the resonance frequency of Me-18 at 
δH1.28 caused a ROE enhancement in the signals at δH 3.92 (H-2, 1.03 CH-
5). Consequently, the structure of 18 will be trachyloban-2α,6β,19-triol. 
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Fig. 1.9 NMR spectra of compound 18 
Compound 10 (Fig. 1.10) was isolated as white substance. 10 showed an 
HRESIMS spectrum with molecular weight of m/z: 319,2267 [M+H]+,which 
was in agreement with the molecular formula C20H30O3 that indicated six 
degrees of insaturations. Comparison of the 1H and 13C NMR data of 10 with 
those of 18 (Tab. 1.5) indicated that both compounds had similar skeleton 
and substitution pattern. The only difference was that an oxo group in the 
13C NMR spectrum showing a low-field signal at 214.8 ppm, was present at 
position 2 in 10 instead of the hydroxy group present at the same position in 
compound 18. This conclusion was verified by the HMBC correlations H2-
1/C-2, C-3 and H2-3/C2,C5,C3 and H5/C7,C1,C3,C8,C9. Accordingly, 
compound 10 was identified as trachyloban-6β,19-dihydroxy-2-one. 
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Fig. 1.10 NMR spectra of compound 10 
Compound 19 (Fig. 1.11) was obtained as white substance. Its HRESIMS 
(m/z: 335.2215) suggested a molecular formula of C20H30O4 which was 
consistent with six degrees of insaturation which were immediately 
identifiable by NMR spectroscopic data (Tab. 1.6). The NMR resonances 
consist in cyclopropane ring (δH 0.89,1.16; δC 18.9, 22.3, 30.0), two 
hydroxymethylen groups at δH 3.94, 3.54 and 3.57; δC 67.5, 66.7); one 
hydroxymethine group at δH 3.99 and δC 68.4; as well as one carbonyl group 
(δC 214.4 attributable to one ketone). In the absence of any other sp, or sp2 
carbons the structure of 19 must be pentacyclic. The 1H NMR spectrum of 
19 exhibited two methyl singlets at δH 1. 
16 and 1.30. All the spectroscopic data suggest that 19 is a trachyloban 
derivative (Midiwo et al., 1997). The hydroxymethylenes groups were 
located at C-19 and C-17 on the basis of the HMBC cross peak of H2-19 
with C-5, C-4 and C-18, Me-18 with C-19, C-4 and C-3, H2-17 with C-15, 
C-13 and C-14, H2-14 with C-9, C-16, C-12, C-7. Long range correlation 
were also observed between H-6 and C-5, C-9,C-8,C-14; between H15 and 
C-13,C-8,C-7. 
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1-D TOCSY and COSY spectra suggest the presence in the molecule of two 
spin system H5__H7, H9__H14. Direct evidences of the substituent sites were 
derived from the HSQC and HMBC correlations which also allowed the 
assignment of all the resonances in the 13C NMR spectrum. 
These results were confirmed by the chemical shift of the respective carbons 
which matched well with related trachylobane (Fraga et al., 2011; Midiwo 
et al., 1997). The relative configuration of the oxymethylene at 17 was 
deduced to be β-orientated by 1D ROESY NMR selective experiments that 
showed correlaation peaks between H-17 and H-12, and H-13 
Therefore, compound 19 was found to be trachyloban-6β,17,19-trihydroxy-
2-one. 
 
Fig. 1.11 NMR spectra of compound 19 
Compound 20 (Fig. 1.12) was obtained as white substance, had a molecular 
formula C20H30O4 based on its HRESIMS (m/z: 335.2216 [M+H]
+ and the 
1H and 13C NMR data (Tab. 1.6) suggesting six degrees of unsaturation. 
Spectroscopic data interpretation indicated that the structure of 20 was 
similar to 19. Comparison of the 13C NMR spectrum of compound 20 with 
that of 19 established a difference in the chemical shift of C-6 [δC 21.5 vs 
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68.7; δH 1.76 and 1.77 vs 4.00 (td, J = 11.0, 11.0, 4.0)], implying that the 
oxymethine was replaced by a methilene, and in the chemical shift of C-18 
(δC 64.3 vs δC 31.4; δH 3.48 and 3.59 vs 1.30 s), implying that the methyl 
was replaced by a hydroxymethylene group. Analysis of HMBC data 
confirmed the positions of these substituents, showing the cross peaks H-
5/C-7, H2-6/C-5, H2-6/C-10, H2-7/C-6 and H2-3/C-18, H-5/C-18, H2-19/C-
18, H2-18/C-3, H2-18/C-4, H2-18/C-5, H2-18/C-19, respectively. 
The structure of 20 was thus assigned as trachyloban-17,18,19-trihydroxy-
2-one. 
 
Fig. 1.12 NMR spectra of compound 20 
Compound 22 was a white oil-like substance, had the molecular formula 
C20H32O4 as deduced from HRESIMS (m/z: 337.2371 [M+H]
+, calcd for 
336.2301) indicating five degrees of unsaturation. The NMR analysis (Tab. 
1.7) displayed four oxygenated groups, namely three oxymethilenes [δC 
63.4, δH 3.76 (d, J = 11.1 Hz), 3.90 (d, J = 11.1 Hz); δC 72.2, δH 3.50 (d, J 
= 11.2 Hz), 3.59 (d, J = 11.2 Hz); δC 67.5, δH 3.56 s] and one oxymethine 
(δC 68.9, δH 3.91). Two oxymethilenes (δC 63.4 and δC 72.2) were located at 
C-4 of the decaline system, C-18 and C-19, respectively, on the basis of the 
HMBC correlations of their protons to C-3, C-4, C-5. The remaining 
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oxymethylene with equivalent protons showed HMBC correlations to C-12, 
C-13, C-15 and C-16 and was thus placed at C-16. The 1H-1H COSY 
correlations of the oxymethine proton (δH 3.91) with H-5 and H2-7 and the 
HMBC correlations from this proton to C-4, C-10 and C-8, and from H-5 
and H2-7 to the oxymethine carbon (δC 68.9) indicated that this group was 
located at C-6. The strong cross-peaks H2-17/ H-12 and H2-17/H-13, as well 
as the correlations H2-19/H3-20 and H3-20 /H-6 observed in the 1D- ROESY 
spectrum, allowed us to conclude that the C-17, C-19 and H-6 were in the 
β-orientation. 
Thus, 22 was elucidated as trachyloban-6β,17, 18,19-tetraol. 
22 
Compound 24 (Fig. 1.13) was obtained as white oil-like substance. The 
HRESIMS of 24 revelled a molecular ion at m/z: 335.2218 [M+H]+ together 
with a minor ion at m/z: 313.2117 corresponding to the loss of a carboxylic 
group from the previous specie. This information, along with the 13 C NMR 
spectra which sorted 20 carbons into two methyls, seven methilenes, five 
methines, four quaternary carbons and one carboxylic group, allowed the 
determination of the molecular formula as C20H30O4 and a trachylobane 
nucleus for 24. The molecular formula along with 13C NMR data account 
for six degrees of insaturation. Comparison of the 1H and 13C-NMR data of 
24 (Tab. 1.7) with those of 19 indicated a close structural similarity of these 
compounds. The comparative analysis of the 13C NMR data of 24 with those 
observed for compound 19 revealed a shielded signal attributable to one 
carboxyl group at δC 181.3 (C-17), in place of the signals of the 
oxymethylene group at δC 67.4 observed in 19. Moreover, in contrast to the 
observation of keto group at position 2 in compound 19, the 1H NMR 
spectrum of 24 indicated the presence of methylene resonances at δC 18.8, 
δH 1.37 and 1.51. 1D-ROESY data and coupling constants analysis 
confirmed that 24 possessed the same relative stereochemistry of 19. This 
compound was established as trakyloban-6β,19 dihydroxy,17oic-acid. 
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Fig. 1.13 NMR spectra of compound 24 
Successively, MIC values of all the pure compounds were determined 
against S. aureus and C. albicans. Flavonoids, 1,3-7 and 11 showed 
moderate activity (data not shown). Only compound 2, 3, 8 and 27 showed 
interesting antibacterial activity (Fig.1.14) (Tab 1.2). 
Tab. 1.2 MIC values of the compounds 2, 3, 8, 27 
 
 MIC (μg/mL) 
 Antibacterial activity Antifungal activity 
compounds 
Staphylococcus aureus Candida albicans 
MIC50 MIC100 MIC2 MIC0 
2 40 70 60 140 
3 8 25 30 100 
8 50 100 100 > 200 
27 45 150 100 > 200 
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Fig. 1.14 Antibacterial activity of pure compounds 2 and 27 against S. aureus and C. 
albicans 
The ability of compounds 2, 3, 8 and 27 to inhibit the biofilm formation of 
C. albicans and S. aureus was investigated. The blue-violet colour is 
indicative of biofilm formed on microtiter plates. The biofilm quantification 
using CV recovered with 200 μl of acetic acid, is reported in Fig. 1.15. 
Compound 3 was the most effective. Compared to the control cells (cells 
treated with only vehicle), compound 3 at a concentration of 40 μg/mL was 
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able to inhibit 50% of bacteria biofilm and 90% of Candida biofilm 
formation. 
 
Fig. 1.15 Ability of compounds 2, 3, 8 and 27 to inhibit the biofilm formation of C. 
albicans and S. aureus 
The antimicrobial activity obtained from P. punctulata extracts and 
compounds was similar to those reported for similar extracts. As expected 
the flavonoid derivatives manifested a good antibacterial activity on S. 
aureus and C. albigans. In conclusion, the dichloromethane extract and six 
fractions were variously active against gram positive and Candida albigans, 
the potency expressed by the crude extract is of particular interest and could 
have application as antibacterial preparation.
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Tab. 1.3 1H and 13C NMR data of compounds 14–30 (CD3OD, 600 MHz, J in Hz)a 
  Compounds 
Position  14   30  
  δH δC  δH δC 
1 
 0.87; 
1.84a 
39.0 
 0.93; 
1.81 
39.7 
2 
 1.58a; 
1.66a 
27.7 
 1.70; 
1.84 
27.9 
3  3.15 dd (4.4, 11.7) 79.3  3.14 dd (12.0. 4.5) 80.1 
4  - 39.5  - 39 
5  0.80a 56.2  0.85 56.0 
6 
 1.57a 
1.58a 
19.7 
 1.61; 
1.77 
20.1 
7 
 1.55a; 1.68a 
42.6 
 1.55 
1.71 
42.9 
8  - 41.3  - 46.0 
9  1.10 d (8.9) 59.3  1.1 59.0 
10  - 40.0  - 38.9 
11  1.69a; 1.81a 27.7  1.62; 1.70 28.0 
12  3.92 m 67.7  3.9 67.0 
13  1.96a 56.8  2.14 54.0 
14 
 
1.48a; 2.26 d (11.7) 32.7 
 1.48; 
2.28 
32.1 
15 
 
1.59a; 1.60a 58.4 
 1.44 
1.57 
54.2 
16  - 79.0  - 81.0 
17 
 
1.34 s 25.2 
 3.58 (13.0); 
3.65 (13.0) 
66.0 
18  0.99 s 29.3  0.81 s 15.6 
19  0.81 s 16.7  0.98 s 28.5 
20  1.26 s 16.3  1.25 s 16.4 
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
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Tab. 1.4 1H and 13C NMR data of compounds 21–23 (CD3OD, 600 MHz, J in Hz)a 
  Compounds 
Position  21   23  
  δH δC  δH δC 
1 
 0.74 t (13.6, 13.6);  
2.19a 
50.0 
 1.42a 
1.77a 
50.6 
2  3.83 br ddd (15.2, 13.6, 5.2) 64.3  3.95a 65.8 
3 
 1.03 t (15.6, 15.2);  
1.90 dd (15.6, 4.7) 
48.7 
 1.39a; 
1.89 dd (13.1, 3.9) 
36.6 
4  - 41.5  - 45.1 
5  1.09 d (13.0) 61.1  1.04 d (11.0) 52.5 
6  4.08 ddd (14.0, 13.0, 4.6) 69.4  3.99a 68.2 
7 
 1.69a;  
1.74a 
51.2 
 
1.58a; 1.74a 50.0 
8  - 43.7  - 45.0 
9  1.19 d (6.9) 56.8  1.29 br d (8.1) 57.0 
10  - 43.3  - 43.3 
11 
 1.72a;  
1.73a 
18.9 
 
1.63a; 1.80a 19.7 
12 
 1.71a;  
1.55 m 
33.6 
 
1.57a; 1.73a 34.0 
13  2.68 br s 44.7  2.69 br s 44.9 
14 
 1.27 dd (13.5, 5.4);  
2.04 dd (13.5, 1.3) 
41.0 
 1.25 dd (11.5, 4.6); 
1.99 br d (11.5) 
40.5 
15 
 2.18a;  
2.20a 
48.9 
 
2.14 br s  49.96 
16  - 161.7  - 155.8 
17 
 4.81 br s;  
4.85a 
103.4 
 4.80 s; 
4.88a 
104.1 
18 
 
1.30 s 32.3 
 3.62 d (11.0); 
4.03a 
65.4 
19 
 3.52 d (10.6);  
3.97 d (10.6) 
67.3 
 3.47 d (11.1); 
4.02a 
67.8 
20  1.21 s 20.0  1.32 s 25.6 
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
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Tab. 1.5 1H and 13C NMR data of compounds 25–27–28 (CD3OD, 600 MHz, J in Hz)a 
Compounds 
  27   28   25  
Position δH δC  δH δC  δH δC 
1 
 
1.95 d (16.6); 
2.57 d (16.6) 
56,6 
 
0.94 ddd (12.3, 
11.7, 4.9); 1.82a 
42,0 
 1.38a; 
1.67 dd (13.9, 
4.7) 
46.3 
2 
 
- 215,2 
 1.45a; 
1.62a 
19,4 
 
4.14 m 67.9 
3 
 
2.07 d (15.0); 
2.69 d (15.0) 
51,4 
 
1.11a; 
1.60a 
39,8 
 1.49a; 
1.82 dd (13.9, 
3.8) 
41.4 
4  - 44,7  - 41,6  - 38.5 
5  1.34 d (12.2) 59,6  1.08a 61,0  1.24 d (8.8) 48.2 
6 
 4.04 ddd (11.2, 
10.8, 4.0) 
68,7 
 4.04 ddd (11.0, 
10.8, 3.5) 
70,1 
 0.88 m; 
1.92 br t (12.4) 
28.0 
7 
 1.88 m; 
1.67a 
51,3 
 1.64a; 
1.84a 
52,2 
 1.19a; 
1.38a 
39.7 
8  - 45,2  - 45,9  - 51.0 
9  1.26 br d (7.9) 56,7  1.07a 58,4  1.33a 52.7 
10  - 43,3  - 39,3  - 39.1 
11 
 1.54a; 
1.70a 
19,6 
 1.44a; 
1.65a 
19,1 
 1.46a; 
1.48a 
20.0 
12 
 1.55a ; 
1.68a 
26,8 
 1.54a; 
1.69a 
27,2 
 1.20a; 
1.37a 
39.8 
13  2.11 br s 46,3  2.07 m 46,3  1.32a 38.8 
14 
 1.81 dd (12.0, 
4.6); 
1.90 dd (12.0, 
3.1) 
37,9 
 
1.77 dd (12.0, 
5.0); 
1.93 br d (12.0) 
38,8 
 
1.72 d (11.8); 
2.11 m 
24.8 
15 
 1.53 d (14.7); 
1.65a 
53,6 
 1.51 d (14.4); 
1.62a 
53,8 
 1.22a; 
1.31a 
58.2 
16  - 82,3  - 82,5  - 72.5 
17 
 3.65 d (11.4); 
3.75 d (11.4) 
66,7 
 3.64 d (11.3); 
3.74 d (11.3) 
66,7 
 
1.28 s 30.4 
18 
 
1.30 s 31,2 
 
1.23 s 31,4 
 3.09 d (11.0); 
3.37a 
71.4 
19 
 3.75 d (11.0); 
4.02 (11.0) 
68,1 
 3.44 d (10.6); 
3.98 d (10.6) 
67,6 
 
0.98 s 20.5 
20  1.31 s 21,1  1.18 s 20,4  1.34 s 18.1 
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
Chapter 1 Psiadia punctulata (DC.) Vatke (Asteraceae) 
 
70 
Tab. 1.6 1H and 13C NMR data of compounds 10-18 (CD3OD, 600 MHz, J in Hz)
a 
  Compounds 
Position  10   18  
  δH δC  δH δC 
1 
 1.95 m; 
2.19 d (15.3) 
55.0  
1.22a; 
1.44a 
48.4 
2  - 214.1  3.95a 65.8 
3 
 2.08 m; 
2.48 d (14.9) 
52.3  
1.30a; 
1.52a 
44.1 
4  - 44.5  - 40.0 
5  1.39a 60.2  1.04 d (10.5) 56.9 
6  3.96 br dd (11.0, 3.8) 68.8  3.96a 68.0 
7 
 1.55a; 
1.72a  
48.5  
1.44 m; 
1.47a 
48.1 
8  - 41.4  - 41.8 
9  1.41a 53.0  1.32 dd (5.0, 1.9) 54.2 
10  - 44.3  - 42.0 
11 
 1.68a; 
1.91 m 
20.5  
1.79 m; 
2.06a 
20.4 
12  0.65 br d (7.4) 21.4  0.66 br d (7.8) 21.5 
13  0.88 dd (7.7, 2.5) 25.3  0.89 br dd (7.8, 3.1) 25.4 
14 
 1.31 d (12.7); 
2.05 d (12.1) 
34.1  
1.29a; 
2.08a 
34.2 
15 
 1.36a; 
1.50a 
51.2  
1.35 d (11.1); 
1.50 d (11.1) 
51.4 
16  - 23.2  - 23.1 
17  1.15 s 20.6  1.17 s 20.6 
18  1.27 s 31.4  1.29 s 29.5 
19 
 3.48 d (10.9); 
3.90 d (10.9) 
68.0  
3.34a; 
4.03 d (10.9) 
69.3 
20  1.11 s 17.4  1.23 s 21.6 
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
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Tab. 1.7 1H and 13C NMR data of compounds 19–20 (CD3OD, 600 MHz, J in Hz)a 
  Compounds 
Position  19   20  
  δH δC  δH δC 
1 
 2.00a; 
2.23 d (15.3) 
54.9  
2.03a; 
2.21 d (9.2) 
55.4 
2  - 214.8  - 215.5 
3 
 2.14a; 
2.52 d (15.0) 
52.2  
2.39 m; 
2.51 d (8.4) 
45.5 
4  - 44.2  - 49.1 
5  1.45a 60.0  1.91 d (11.6) 48.5 
6 
 
4.00 ddd (11.4, 11.0, 4.0) 68.7  
1.76 a; 
1.77 a 
21.5 
7 
 1.60 t (12.5, 12.5); 
1.77a 
48.5  
1.55a; 
1.57a 
39.6 
8  - 41.5  - 42.0 
9  1.46a 52.9  1.56a 53.7 
10  - 44.5  - 44.0 
11 
 1.76a; 
2.00a 
20.5  
1.48a; 
1.99a 
20.6 
12  0.89 dd (7.9, 3.1) 19.6  0.87 br d (8.7) 19.7 
13  1.16a 23.1  1.12 m 23.1 
14 
 1.36 m; 
2.12a 
33.7  
1.23 dd (12.8; 2.8); 
2.11 br d (12.0) 
33.4 
15 
 1.52 d (11.4); 
1.70 d (11.4) 
46.7  
1.47a; 
1.63 d (14.5) 
46.5 
16  - 30.2  - 30.5 
17  3.57 br s 67.4  3.56 br s 67.6 
18 
 
1.30 s 31.4  
3.48a; 
3.59a 
64.3 
19 
 3.52 d (11.0); 
3.94 d (11.0) 
67.8  
3.46a; 
3.61a 
66.9 
20  1.15 s 17.5  1.03 s 16.6 
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
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Tab. 1.8 1H and 13C NMR data of compounds 22–24 (CD3OD, 600 MHz, J in Hz)a 
  Compounds 
Position  22   24  
  δH δC  δH δC 
1 
 0.80; 
1.56 
39.9  
0.87 t (11.8); 
1.57a 
40.0 
2 
 1.38; 
1.50 
18.1  
1.37a; 
1.51a 
18.8 
3 
 1.24; 
1.74 
30.0  
1.12a, 
1.59a 
39.6 
4  - 47.5  - 40.5 
5  1.15 d (11.0) 58.2  1.03 d (10.8) 61.8 
6  3.90 ddd (13.5, 13.0, 4.3) 67.7  3.99 ddd (11.4, 11.2, 3.8) 69.8 
7 
 1.53; 
1.97 
48.9  
1.55a; 
1.70 dd (12.3, 3.7) 
48.7 
8  - 42.0  - 41.2 
9  1,23 53.3  1.24a 53.6 
10  - 38.6  - 41.7 
11 
 1.97; 
2.00 
20.0  1.80a; 1.99 br t (12.9) 20.5 
12  0,89 18.7  1.23a 31.2 
13  1,07 22.0  1.81a 31.8 
14 
 1.30; 
2.14 
33.6  
1.36a; 
2.20 d (12.3) 
34.0 
15 
 1.46; 
1.66 
46.7  
1.56a; 
1.90 (11.7) 
45.2 
16  - 29.0  - 25.2 
17  3.56 s 66.7  - 178.0 
18 
 3.71 d (12.8); 
3.92 d (12.8) 
63.0  1.20 s 31.8 
19 
 3.50 d (10.9); 
3.79 d (10.9) 
71.0  
3.46 d (11.7); 
3.96 d (11.7) 
67.6 
20  1.06 s 15.0  1.08 s 16.3 
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
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Known compounds of Psiadia punctulata exudate 
   
1 2 3 
   
4 5 6 
   
7 8 9 
   
11 12 13 
 
  
15 16 17 
  
26 29 
Fig. .1.16 Know compounds of P. punctulata 
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2.1 Acanthaceae family 
Acanthaceae is a large pantropical family consisting of approximately 240 
genera and 3250 species. In the New World there are approximately 85 
genera and 2000 known species. The two largest neotropical genera, Justicia 
(350-600 species) and Ruellia (ca. 250 species), are prominently distributed 
in Bolivia with 48 and 28 species, respectively (Wood, 2004). Plants of the 
Acanthaceae have found application in African and Asian folk medicine for 
the treatment of cancer  heart disease, gonorrhea, and snake-bite (Pettit et 
al., 1984). Traditionally, the Acanthaceae leaves are used externally for 
wounds, but antifungal, cytotoxic, anti-inflammatory, anti-pyretic, anti-
oxidant and insecticidal, activities are also reported especially in Middle 
East areas (Awan et al., 2014; Watt, 1962). 
2.2  Hypoestes genus 
Hypoestes, an important genus belonging to Acanthaceae family, consists of 
150 species of woody-based, evergreen perennials, sub-shrubs and shrubs 
from open woodland in South Africa, Madagascar and S.E. Asia (Ellis 
1999). Three species of the genus Hypoestes are reported in Southern Africa 
folk medicine. Hypoestes aristata (Vahl) Sol. ex Roem. & Schult native of 
tropical subSaharan area is used by amaZulu for the treatment of sore eyes 
(Steenkamp, 2003). Hypoestes ssp decoction is used in the treatment of 
breast disease. Roots are chewed for influenza, cough, colds and sore throats 
in East Africa (Kokwaro, 1976) (Kokwaro 1976). 
The plants belonging to Hypoestes genus are the main source of 
fucosicoccane diterpenes so far identified in higher plants and fungi (Ellis, 
2000). 
 
2.3 Previous phytochemical studies of Hypoestes genus 
Several phytochemical studies have been carried out on Hypoestes species 
such as H. serpens L. (Rasoamiaranjanahary et al., 2003; Andriamihaja et 
al., 2001), H. verticillaris (Linn. f.) Soland. (Al-Rehaily et al., 2002), H. 
roseae P.Beauv. (Ojo-Amaize et al., 2001) (Adesomoju et al., 1983; 
Adesomoju and Okogun, 1984) and H. purpurea L. (Shen et al., 2004). 
Diterpenes belonging to the class of fucossane, isopimaranes and labdane 
are the main skeleton synthetized by these plant species. 
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Isopimaranes are common constituents of conifers and are biosynthetically 
originated from the labdane-derived (+)-copalyl pyrophosphate (Otto and 
Wilde, 2001). Some isopimaranes exhibit interesting biological properties 
such as ntitumoral, cytotoxic, antimicrobial, tumour-promoting and anti-
inflammatory (Ambrosio et al., 2006; Grace et al., 2006; Phuong et al., 
2006). 
Labdane skeleton is a natural bicyclic diterpene forming the structural core 
of a wide variety of natural diterpenes collectively known as labdanes. A 
variety of biological activities have been determined for labdane diterpenes 
including antibacterial, antifungal, antiprotozoal, and anti-inflammatory 
(Cocker and Halsall, 1956; Rahman, 2012). 
Fusicoccane diterpenes are powerful phytotoxins synthetized by several 
fungi species (Graniti, 1964) but a large number of these molecules is also 
synthesized by plants and particularly by Hypoestes ssp. Several biological 
activities are reported for fusicoccanes, mainly antimicrobial, anticancer and 
hypotensive activity (Gilabert et al., 2011; Mothana et al., 2009; Zapp et al., 
1994) All this compounds are characterized by a complex 5-8-5 
diciclopenta-cyclooctane nucleus (Muromtsev et al., 1994). Ditepernes 
isolated from Hypoestes ssp are shown below (Fig..2.1) 
 
 
 
 
7β-hydroxyisopimara-8,15-
dien-14-one 
 
 
Ketonepoxide 7β-hydroxyisopimara-
8(14),15-dien-1-one 
 
   
7β-acetoxyisopimara-
8(14),15-dien-1-one 
1 β,14α-
dihydroxyisopimara- 7,15-
diene 
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Fusicoserpenol A Serpendion Verticillarone Dolaserpenoc acid A 
 
   
Hypoestoxide Roseanolone Roseadione Roseatoxide 
 
 
 
 
Hypopurin A Hypopurin B Hypopurina C Hypopurin D 
Fig. 2.1 Diterpenes of Hypoestes spp  
2.4 Hypoestes forskaolii (Vahl) Roem. & Schult 
Synonym: Hypoestes latifolia Hochst. ex Nees; Justicia paniculata Forssk.; 
Justicia verticillaris L. f. Roem. & Schult. 
The plant is widely distributed in many African countries as well as in high 
mountains of the Arabian Peninsula. In Saudi Arabia the plant has several 
popular names, among them “Nadgha”, “Majra”, 
“Qumaylah”.(Andriamihaja et al., 2001). 
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The leaves of this plant have bitter taste so It’s not edible plants for animals. 
H. forskaolii is used popularly as natural insecticide, the decoction of this 
plant is used to wash the goats infested by flea, the fresh leaves are pasted 
and added to milk to attract and to kill the flies. The fresh leaves are applied 
to wounds to accelerate the healing. The fresh stems are used to massage the 
head scalp to kill head lice and to destroy its eggs. Goats with skin diseases 
specially in the breasts are exposed to vaporise of the burned H. forskaolii 
(Padysakova et al., 2013). 
2.4.1 Previous phytochemical studies on Hypoestes forsskaolii 
The diterpenes isolated from the leaves of Hypoestes forsskaolii are shown 
below (Al Musayeib et al., 2014) 
  
 
Hypoestenonols A 
 
Hypoestenonols B 
 
Hypoestenone 
 
 
 
 
Verticillarone 17 – Hydroxyhypoestenone 8(9) α – Epoxyhypoestenone 
Fig. 2.2 Diterpenes of H. forskaolii leaves 
2.4.2 Biological activities 
Several studies have shown that fusicoccanes have multiple biological 
activities. In particular, serpendione (Fig. 2.1) isolated from H. serpens was 
able to reduces of 92.2% the contractile action of noradrenaline at 
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concentration of 0.05mg / mL. This result supports the use of H.serpens for 
the treatment of hypertension. 
Diterpenes isolated from H. forskalei as hypoestenone and 8 (9)-α-
epoxyhypoestenone, showed antimicrobial activity against the pathogenic 
fungus Cryptococcus neoformans, with a MIC respectively of 20 μg/mL and 
50 μg/mL. Hypoestenone showed also a moderate activity against 
Pseudomonas aeruginosa with MIC of 45 μg/mL, and against Plasmodium 
falciparium with IC 50 of 2800 ng/mL. 
2.4.3 Anthelmintic activity of plant extracts. 
Infections by gastrointestinal nematodes (GIN) remain a major constraint to 
ruminants’ health, welfare and productive performance worldwide 
(Dipineto et al., 2013; Rinaldi et al., 2015a). These parasites cause direct 
and indirect losses in different ways such as lowered fertility, reduced work 
capacity, reduction in food intake, low weight gain and low milk productions 
(Rinaldi et al., 2015b). The administration of synthetic anthelminthics has 
long been considered the most effective way of controlling helminth 
infection to minimize losses caused by these parasites (Charlier et al., 2014) 
but the use of these drugs has some disadvantages, such as development of 
anthelmintic resistance (AR), high cost, risk of environmental pollution 
(Wagil et al., 2015). The availability and affordability of systemic 
anthelminthics to small-scale sheep farmers is a major problem in many 
developing countries (Adamu et al., 2010). This problem justifies the need 
for alternative control methods such as the use of traditional medicinal plants 
(Githiori, 2004) that are being examined in different parts of the world. The 
screening and proper evaluation of medicinal plants could offer possible 
alternative that may both be sustainable and environmentally acceptable 
(Eguale et al., 2007). 
Anthelmintics derived from plants used for the treatment of parasitic 
infections in human and animals can offer an alternative to minimize some 
of these problems (Akhtar et al., 2000). One of the novel approaches 
investigated is the use of indigenous plant preparations commonly used 
against human parasites. The benefit of using these as possible livestock 
dewormers is that they are non-toxic and inexpensive, features that are 
important for farmers in developing countries (Taylor et al., 2001). These 
possible ethnoveterinary alternatives would be viable for small scale 
livestock farmers who cannot afford the allopathic drugs and/or for larger, 
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conventional farmers who cannot rely on the use of conventional veterinary 
products in their flocks (Gradé et al., 2008). Furthermore, plant-derived 
anthelminthic products are advantageous as they are less toxic, 
biodegradable and environmentally friendly (Hammond et al., 1997). 
In the last decade, some plants of Acanthaceae family have been studied for 
their anthelmintic activity (Al-Shaibani et al. 2008, Adamu et al. 2010), 
AIM 
For all these reasons the aim of this study was to investigate the in vitro 
anthelmintic activity of the leaves extracts (n-hexane, chloroform, 
chloroform: methanol 9:1, methanol) of H. forskaolii, plant belonging to 
Acanthaceae family, on the eggs of GIN infecting sheep in south Italy and 
to investigate their secondary metabolites. 
2.5 Experimental 
2.5.1 Plant material 
The aerial parts of H. forsskaolii were harvested at Wadi Thee Ghazal, Taif 
in Saudi Arabia, in September 2013. The plant was identified by Dr. Ammar 
Bader. A sample for aerial parts (N ° SA-EN 2013-2), is deposited in the 
herbarium of the Faculty of Pharmacy of Pharmacognosy laboratory at 
Umm Al-Qura University, Saudi Arabia. 
2.5.2 Extraction and isolation 
The aerial parts (505.0 g) dried and grinded were macerated with increasing 
polarity solvents: n-hexane, chloroform (CHCl3), chloroform / methanol 9: 
1 (CHCl3:CH3OH) and methanol (CH3OH). The entire extraction process 
lasted about three weeks, during which the solvent has been renewed 
continuously (3X2L). The residues obtained were filtered and evaporated at 
reduced pressure (Fig. 2.3). 
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Fig. 2.3 Extracts of H. forskaolii leaves 
 
Part of the n- hexane extract (5 g) was dissolved in 15 ml of n-hexane and 
separated on silica gel column, eluted with step gradients of n-hexane: 
CHCl3(100:0, 90:10, 80:20, 70:30, 50:50 and 0:100) and CHCl3:MeOH 
(100:0, 90:10, 80:20, 70:30, 50:50 and 0:100) Fractions of 25 mL were 
collected, analysed by TLC and grouped into 9 main fractions based on the 
similarities revealed on TLC (A-I). Fraction F (2848 mg) was separated by 
silica gel CC eluting with CHCl3 followed by increasing concentrations of 
MeOH (between 1% and 100%). Fractions of 15 mL were collected, 
analysed by TLC pointed and sprayed with a solution of Ce2(SO4)2/H2SO4, 
65% and lastly grouped into TLC and grouped into 6 fractions (F1-F6) (Fig. 
2.4). 
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Fig.2.4 Separation scheme of H. forskaolii n-hexane extract 
 
Fraction D (86.0 mg) was subjected to RP-HPLC using a C18 µ-Bondapak 
column (30 cm x 7.8 mm, 10 µm Waters, flow rate 2.0 mL/min). (MeOH-
H2O, 39:11) to give pure compound 1 (2.5 mg, tR = 75 m), 2 (1.2 mg, tR = 
90 m). Fraction E (440.8 mg) was subjected to RP-HPLC (MeOH-H2O, 
75:25) to give pure compounds 3 (2.5 mg, tR = 1h, 12m), 2 (2.5 mg, tR = 1 
h, 20 m) and 5 (2.5 mg, tR = 1 h,30 m). 
Fraction G (700.0 mg) was subjected to RP-HPLC (MeOH-H2O, 7:3) to give 
pure compounds 6 (2.5 mg, tR = 5 m), 7 (2.5 mg, tR = 7.5 m) 8 (2.5 mg, tR = 
17.5 m), 9 (2.5 mg, tR = 25 m), 10 (2.5 mg, tR = 42 m) and 11 (2.5 mg, tR = 
44 m). Fraction F3 (280.0 mg) was subjected to RP-HPLC (MeOH-H2O, 
75:25) to give pure compounds 3 (2.5 mg, tR = 20 m), 4 (2.5 mg, tR = 1h, 20 
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m), 5 (2.5 mg, tR = 1 h, 32 m) and 12 (2.5 mg, tR = 1 h, 50 m). Fraction F4 
(523.8mg) was subjected to RP-HPLC (MeOH-H2O, 7:3) to give pure 
compounds 7 (2.5 mg, tR = 5 m), 9 (2.5 mg, tR = 25 m) and 13 (2.5 mg, tR = 
1 h, 22 m). Fraction F5 (688.1mg) was subjected to RP-HPLC (MeOH-H2O, 
65:35) to give pure compounds 7 (2.5 mg, tR = 10 min), 8 (2.5 mg, tR = 27.5 
m), 9 (2.5 mg, tR = 48 m) and 11 (2.5 mg, tR = 75 m). 
2.5.2.1 Compound 1 
Colorless needles  25D : +13.0; for 
1H and 13C NMR spectroscopic data, see 
Tab. 2.1; EI-MS m / z 289.2526 [M + H] + (calcd for C20H32O6; 288.2453). 
2.5.2.2 Compound 2 
Colorless needles  25D :+21.0; for 
1H and 13C NMR spectroscopic data, see 
Tab. 2.1; EI-MS m / z 289.2529 [M + H] + (calcd for C20H32O;288.2453). 
2.5.2.3 Compound 10 
Colorless needles  25D : + 88.1 ° (c 0.06 CH3OH); for 
1H and 13C NMR 
spectroscopic data, see Tab. 2.1; EI-MS m / z 303.2320 [M + H] + (calcd for 
C20H30O9; 302.2246). 
2.5.2.4 Compound 13 
Oil  25D : + 93.0; for 
1H and 13C NMR spectroscopic data, see Tab. 2.2; EI-
MS m / z 345.2429 [M + H] + (calcd for C22H32O3; 344.2351). 
2.5.3 Reagents and antibodies 
Fetal bovine serum (FBS) was from GIBCO (Life Technologies, Grand 
Island, NY, USA). The antibodies anti-Cdc2 (mouse monoclonal, sc-8395) 
and anti-phospho (Thr161)-Cdc2 p34 (rabbit polyclonal, sc-101654), were 
obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA); 
appropriate peroxidase-conjugated secondary antibodies were from Jackson 
Immuno Research (Baltimore, PA, USA). 
2.5.4 Cells and treatment 
HeLa (cervical carcinoma), and Jurkat (T-cell leukemia), and cell lines were 
obtained from the American Type Cell Culture (ATCC) (Rockville, MD, 
USA). Cells were maintained in DMEM (HeLa) or RPMI 1640 (Jurkat and 
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U937), supplemented with 10% FBS, 100 mg/L streptomycin and penicillin 
100 IU/mL at 37 °C in a humidified atmosphere of 5% CO2. To ensure 
logarithmic growth, cells were subcultured every two days. Stock solutions 
(50 mM) of purified compounds in DMSO were stored in the dark at 4 °C. 
Appropriate dilutions were prepared in culture medium immediately prior 
to use. In all experiments, the final concentration of DMSO did not exceed 
0.15% (v/v). 
2.5.5 Cell viability and cell cycle  
Cells were seeded in 96-well plates and incubated for the established times 
in the absence (vehicle only) and in the presence of different concentrations 
of compounds and Etoposide as positive control. The day before treatments, 
cells were seeded at a cell density of 1×104 cells/well. The number of viable 
cells was quantified by MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide]) assay. Absorption at 550 nm for each well 
was assessed using a microplate reader (LabSystems, Vienna, VA, USA). In 
some experiments cell viability was also checked by Trypan Blue exclusion 
assay using a Bürker counting chamber. IC50 values were calculated from 
cell viability dose – response curves and defined as the concentration 
resulting in 50% inhibition in cell survival as compared to controls. Cell 
cycle was evaluated by propidium iodide (PI) staining of permeabilized cells 
according to the available protocol and flow cytometry (BD FACSCalibur 
flow cytometer, Becton Dickinson, San Jose, CA, USA). Data from 5000 
events per sample were collected. The percentages of the elements in the 
hypodiploid region and in G0/G1, S and G2/M phases of the cell cycle were 
calculated using the CellQuest or MODFIT software, respectively. 
2.5.6 Statistical analysis 
Data reported are the mean values ± SD from at least three experiments, 
performed in duplicate, showing similar results. Differences between 
treatment groups were analyzed by Student’s t-test. Differences were 
considered significant when p < 0.05. 
2.5.7 Recovery GIN eggs 
Fresh faecal samples containing GIN eggs were obtained from naturally 
infected sheep and processed within 4 hours of collection. Specifically, GIN 
eggs were extracted from the positive samples the mass recovery method, 
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i.e., a method that employs 5 sieves of different dimension (1 mm, 250 µm, 
212 µm, 63 µm and 38 µm) in order to separate the eggs from the faeces. 
(Coles et al., 2006). The latter filter (38 µm) was washed and eggs were 
suspended in deionized water and then visualized under a microscope 
(Leica, 20X) to record if embryonation had not begun. Ten aliquots of 0.1 
ml were taken and the number of eggs counted (Godber et al., 2015). The 
mean of eggs counted in these aliquots was 150 per 0.1 ml of egg 
suspension. 
2.5.8 Faecal cultures 
In order to identify the GIN genera involved in this study, larval cultures 
were needed. An aliquot of faecal positive sample containing GIN eggs was 
broken up finely, using either a large pestle and mortar or spatula and were 
placed in a glass jar or petridishes which was closed and incubated at a 
temperature of about 25 ˚C for 10 days. After incubation, samples were 
examined for larvae using a binocular microscope (Raza et al., 2013). Third 
stage larvae were identified using the morphological keys proposed by van 
Wyk and Mayhew (2013). When a coproculture had 100 or less third stage 
larvae, all were identified; when a coproculture had more than 100 larvae, 
only 100 were identified (Cringoli et al., 2003). 
2.5.9 Egg hatch assay 
The EHA procedure followed that recommended by the World Association 
for the Advancement of Veterinary Parasitology (WAAVP) (Coles et al., 
1992). The protocol to prepare thiabendazole (TBZ, Sigma) solution used 
deionized water with a neutral pH. Thus, for the preparation of solution A, 
50-mg TBZ were dissolved in 5 ml water. Subsequent dilutions were made 
in deionised water (von Samson-Himmelstjerna et al., 2009). Stock solution 
B (1 mg TBZ per ml) was obtained by adding 1 ml of stock solution A (10 
mg TBZ per ml) to 9 ml water, then 400 µl and 1000 µl of stock solution B 
were added to 9.6 ml and 9 ml of water, respectively. Therefore, the final 
concentrations of TBZ in wells were: 0.2 and 0.5 µg per ml. In our study, 
TBZ was used as positive control. 
Five working concentrations were prepared of each H. forskaolii extracts: 1 
mg/ml, 0.5 mg/ml, 0.1 mg/ml and 0.01 mg/ml. Egg suspension (100 µl with 
150 eggs) was placed in plastic wells (24 well tissue culture test plates), 900 
µl of water were added and finally1 ml of each extract concentration were 
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added. Therefore, the final concentrations in wells were: 1 mg/ml, 0.5 
mg/ml, 0.25 mg/ml, 0.05 mg/ml and 0.005 mg/ml. Each sample was tested 
in triplicate and at least two negative control samples were used (including 
the sample in deionized water without any drug/plant extracts). The plates 
were incubated for 48h at 25-27°C and the assay stopped by adding two 
drops of Lugol’s iodine. The eggs and larvae in each well were carefully 
washed in a petri dish marked with a grid and counted on a binocular 
microscope (Coles et al., 2006). Thereafter, the number of larvae present per 
well was counted, and the percentage hatched was determined as the ratio 
between the number of larvae to the number of eggs deposited per well. A 
mean percentage of hatching was calculated for each concentration of each 
plant extracts. 
2.6 Results 
2.6.1 EHA test 
The most prevalent genera of GIN were Trichostrongylus spp.(42.6%), 
followed by Chabertia ovina (22.9%), Cooperia spp. (21.3%), Haemonchus 
contortus (8.1%) and Teladorsagia spp.(5%). 
The results of the EHA for the n-hexane extracts of H. forskaolii, TBZ and 
their water controls are shown in Tab. 2.1. The results showed a mean of 7.1 
% of eggs in negative control (deionized water), a mean of 96.9% of eggs in 
the first positive control (0.2 µg/ml of TBZ) and a mean of 97.2% of eggs 
in the second positive control (0.5 µg/ml TBZ). Tab. 2.1 show that the n-
hexane extract has a percentage of inhibition of egg hatching greater than 
other extracts inhibiting the 30.8% at the concentration of 1 mg/ml showing 
a dose-dependent effect on GIN eggs hatching. The chloroform:methanol 
(9:1) extract of H. forskaolii showed an high turbidity at 1 mg/ml 
concentration, therefore it was impossible to examine the sample with a 
binocular microscope 
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Tab. 2.1 Percentages of GIN eggs and egg hatch after treatment at various concentrations 
with thiabendazole, leaves n-hexane extract of H. forskaolii, and distillated water 
TBZ (µg/ml) 
% egg ± SD % egg hatch ± SD 
0.2 mg/ml  95.00 ± 1.00 5.00± 1.00 
0.5 mg/ml  95.88 ± 0.03 4.12± 0.03 
n-hexane (mg/ml) % egg ± SD % egg hatch ± SD 
0.005 mg/ml 15.00 ± 0.68 85.00 ± 0.68 
0.05 mg/ml 17.82 ± 0.65 82.18 ± 0.65 
0.25 mg/ml 18.81 ± 0.24 81.19 ± 0.24 
0.5 mg/ml 20.00 ± 0.79 80.00 ± 0.79 
1 mg/ml 30.81 ± 0.83 69.19 ± 0.83 
DeionisedWater Control 3.67 ± 1.53 93.33 ± 1.53 
So, the n-hexane extract was studied in order to isolate the secondary 
metabolites. 
2.6.2 Chemical study  
The n-hexane extract of H. forskaolii was separated by silica gel column 
chromatography and RP-HPLC to afford thirteen compounds (1-13) nine of 
which are already known in literature (3-9 and 12). 
The known isolated compounds were three labdane diterpenes named 
Chelodane (3) (Rudi and Kashman, 1992), Kolavelool (4) (Nagashima et al., 
2001), 8,14-labdadien-13-ol (5) (Jian and Xiaozhang, 2000) and six 
fusicoccane diterpenes named 8 (9) α-Epoxy hypoestenone-12 (13) -
anhydrohypoestenone (6) (El Sayed, 2001), Hypoestenone epoxide (7) 
(Muhammad et al., 1997), Dehydrohypoestenone (8) (Muhammad et al., 
1998), Hypoestenone (9) (Muhammad et al., 1997), 13-Hydroxy-7-
oxolabda-8,14-diene (11) (Nagashima et al., 2001), Deoxyhypoestenone 
(12) (Muhammad et al., 1998). 
Compound 1 (Fig. 2.5) was obtained as an amorphous white powder. The 
molecular formula of compound 1 C20H32O was established by 
13C NMR 
and HRMS (obsd m/z 289.2526 for [M+H]+ calcd m/z 288.2453), indicating 
five degree of hydrogen definciences. The 13C NMR of 1 contained 
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resonances for 20 carbons, while a DEPT experiment revealed the presence 
of five methyls, six methylenes, five methines, and four quaternary carbons 
including two sp2 carbons. The NMR data (Tab. 2.2) showed that one of the 
elements of unsaturation was present as double bond, therefore the molecule 
was tetracyclic. 
The 1H NMR and 13C NMR spectra showed the presence of epoxy ring 
resonances (δH 2.88, and δC 57.4 and 65.0). This group was located at C-
8―C-9 on the basis of cross peaks in the 1H-1H COSY spectrum between 
H-9 and H2-10, and of correlations observed in the HMBC spectrum 
between H-9 (δH 2.28) proton and C -7 (δC 52.6), C-17 (δC 17.8), C-11 (δC 
50.8), and Me-17 (δH 1.12) and C -7 (δC 52.6), C-9 (δC 65.0). Furthermore, 
the analysis of the 1H NMR data  showed signals attributable to the presence 
of an isopropyl group at δH 0.80 (3H, d, J = 6.8 Hz, H-19)/δC 19.6 (C-19), 
δH 0.94 (3H,d, J = 6.8 Hz, H-20)/δC 23.3 (C-20) e δH 1.90 (1H, m, H-18)/δC 
29.6 (C-18), the presence of this group was confirmed by 1H-1H COSY 
correlations between H-18 and Me-19 and Me-20; this inferred the presence 
of fusicoccane skeleton (Muhammad et al., 1998), which was supported by 
correlation of the H-18 resonance in the HMBC spectrum to C-13, C-11, C-
20, and of δH 0.80 assigned to Me-19 with C-10, C-12. DQF-COSY and 1D-
TOCSY measurements showing coupling between H2-5 (2.33 m) ―H2-6 
(1.94 m, 1.84 m), H-7 (2.58 dd, J=6.0 and 6.5 Hz) allowed assignment of 
the H-5―H-7 spin system. Likewise, an HMBC correlation to the two H2-5 
resonances established the  3,4 double bond at δC 126.0 (C-4), 125.4 (C-3). 
Extensive analysis of NMR spectra allowed the assignment of most 
functional groups to the fusicoccane skeleton (Al-Rehaily et al., 2002). 
1D-TOCSY and COSY experiments provided evidence for the presence in 
the molecule of the segments H-9—H-12, H-14—H-11 and H-12―H-20. 
All protons directly bonded to carbon atoms were assigned on the basis of 
the cross peaks observed in the HSQC spectrum. The quaternary C__O 
resonance at δH 57.4 was assigned to C-8 by HMBC cross peaks between H-
7 and C-8, C-9, C-5, C-3; H-10 and C-8, C-11, and between Me-17 and C-
7, C-9.  
The relative stereochemistry of compound 1 was obtained on the basis of 
1D-ROESY data. The β-orientation of H-9, H-11, H-12 and Me-17 was 
indicated by ROE cross peaks among proton spatially related particularly H-
9 with H-11, and Me-17; and H-12 with H-11 and H-9. This was confirmed 
by chemical shifts of the respective carbons, which matched well with those 
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of related fusicoccane-type diterpenes (Muhammad et al., 1998). The 15-
methyl proton signal at δH 0.67, showed ROE correlations with the signal at 
δH 2.58 (H-7) and 1.90 (H-18), this observation clarified the relative 
stereochemistry between these proton, the relative stereochemistry of 
compound 1 was thus found to be identical to that of relate compound 
roseatoxide (Akindo et al. 1984). On the basis of these data, compound 1 
was characterized as a fusicoccane derivative named 8(9)-epoxy, 3(4) 
fusicoccene 
 
Fig. 2.5 NMR spectra of compound 1 
Compound 2 (Fig. 2.6) was isolated as a colorless, amorphous solid, with 
molecular formula of C20H32O as determined by HRMS, showing a quasi 
molecular ion at m/z 289.2529 [M+H]+, requiring five degrees of 
unsaturation. ESI/MS/MS spectrum showed a single fragment ion at m/z 271 
produced by elimination of a water molecules. 
The carbon resonances at δ 124.4 and 131.0, which was assigned to one 
oleofinic group based on COSY, HSQC, and HMBC data, accounted for one 
degree of unsaturation and suggested the presence of four ring in 2. Results 
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obtained from 1D-TOCSY and COSY experiments established the 
connectivity of protons H-5—H-7, H-9—H-14, H-12—H-20. The 
elucidation of the whole skeleton from the above subunits was achieved on 
the basis of HSQC and HMBC correlations, which also allowed the 
assignment of all the resonance in the 13C NMR spectrum of the pertinent 
carbons (Tab. 2.2). In the 13C NMR spectrum two signals at δ 69.0 and 64.4 
ppm allowed to establish the presence of an epoxy ring which was located 
at C-3/C-4 on the basis of HMBC experiment. Key correlation peaks 
between H-2C-3, H-2C-7, H-5C-3, H-7C-7, H-6C-3, H-6C-
4, H-6C-8 were observed. 
The spin system of ring B was obtained starting from proton at δ 5.68 (H-9) 
which correlated with signals at δ 2.20 and 2.14 (H2-10), 1.69 (H-11), 2.23 
(H-12), 1.90 (H-18), 0.84 (H-19), and 0.92 (H-20), 1.59 and 1.51 (H2-13), 
and 1.59 and 1.48 (H2-14). Moreover, ring B was connected with rings A 
and C by HMBC correlations: H-2/ C-4, C-7, C-11; Me-15/C-3, C-11, C-
14; H-9/C-7, C-11, C-17, C-12, H-6/C-4, C-5, C-8; H-18/C-11, and C-20. 
Therefore, the structure of 2 was defined as 3,4-epoxy-8(9)-fusicoccene. 
 
Fig. 2.6 NMR spectra of compound 2 
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Compound 10 (Fig. 2.7) was obtained as an amorphous white powder. The 
molecular formula of compound 10 (C20H30O2) was established by 
13C NMR 
and HR-MS (obsd m/z 303.2320 for [M+H]+ calcd m/z 302.2246) indicating 
six degrees of unsaturation. The NMR data (Tab. 2.3) showed that three of 
the elements of unsaturation were present as one carbonyl group, and two 
double bonds, therefore, the molecule was tricyclic. 
In the 1H NMR spectrum of 10, two methyl singlets linked to sp2 carbons 
resonating at  1.72 and 1.52 were assigned as C-16 and C-17, respectively; 
while a methyl singlet at  0.83 was assigned as C-15. Two methyl doublets 
at  0.88 (J = 7.0 Hz, Me-19) and  0.95 (J = 7.0 Hz, Me-20) were also 
present. The hydroxymethine resonance at δC 80.0 and δH 3.69 (1H, dd 
J=10.5 and 5.5 Hz) was assigned to C-14 by HMBC cross peaks between 
H-14 and C-1, C-11, C-12, C-15; Me-15 and C-1, C-11, and C-3, and 
between H-12 and C-11, C-1, C-18, and C-19. Three spin systems were 
recognized from 1D TOCSY and DQF-COSY spectra: H-9H-14, H-
6H-7, H-12H-20. In the 1H NMR spectrum one proton signal at δH 5.73 
(m, H-9) was also present showing in HSQC experiment a cross peak with 
a carbon to δC 130.0 indicating the presence of a double bond. The double 
bond was located at C8-C9 on the basis of the HMBC longe range 
correlations observed between H-9/C-7, H-9/C-11, and H-9/C-17,  and Me-
17/C-9, Me-17/C-8,   Me-17/C-7, and H-7/C-3, H-7/C-5, H-7/C-9. 
The tetra-substituted double bond located between C-3 and C-4 was 
supported by the HMBC correlations of Me-16 with H-2 and H-6; C-3 with 
H-7, H-2. Moreover the HMBC spectrum showed correlations between the 
proton signal at H 4.15 (H-7) and C-3, C-5, C-8; between the signal at H 
3.18 (H-2)  and C-7, C-3, C-4, C-15: between the signal at H 1.83 (H-11) 
and C-1, C-2,  C-12, C-14 locating the α,β unsaturated carbonyl group at C-
5 Δ3.4. 
The relative stereochemistry was assigned on the basis of the correlations 
observed in 1D-ROESY spectrum and by comparison with the coupling 
constants and the 1H NMR chemical shifts reported in the literature 
(Muhammad et al. 1997,1998). In fact, in the 1D- ROESY spectrum 
correlations between H-7 (δH 4.15), Me-15 (δH 0.83), H-18 (δH 1.95) 
indicated that they were placed on the same side of the molecule. The 1D-
ROESY indicated also that the protons at position 11, 12, and 14 were syn, 
relative to each other (Musayeib, et al 2014). 
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From these results, the structure of compound 10 was determined as 
fusicoccane derivative and named Hypoestanonol H 14-
hydroxy,3(4),8(9)diene-fusiccon-5-one. 
 
 
 
Fig. 2.7 NMR spectra of compound 10 
Compound 13 (Fig. 2.8) was obtained as an amorphous white powder. The 
molecular formula of compound 13 C22H32O3 was established by 
13C NMR 
and HRMS (obsd m/z 345.2429 for [M+H]+ calcd m/z 344.2351) indicating 
six degree of unsaturations. The 13C NMR of 13 contained resonances for 
22 carbons, while a DEPT experiment revealed the presence of six methyls, 
four methylenes, six methines, and six quaternary carbons including four sp2 
carbons, and one carbonyl group. The NMR data (Tab. 2.3) showed that 
three of the elements of unsaturation were present as two double bonds and 
one carbonyl, therefore the molecule was tricyclic.  
An α,β unsaturated carbonyl group occurring in ring A (Δ3,4) was deduced 
from the signal due to a methyl linked at a sp2 carbon at δ 1.70 and from the 
sub-spectrum obtained by a 1D-TOCSY experiments. The irradiation of the 
signal at δ 4.12 (H-7) showed connectivity with chemical shifts at δ 2.48 
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(H2-6), 1.51 (Me-17). These observations were substantiated by the HMBC 
correlations of Me-16 (δ 1.70) and C-5, and C-4; H-7 (δ 4.12) and C-5, C-4, 
and C-2; H-2 (δ 2.90) and C-1, C-3, C-4 and C-7. The spin system of ring B 
was obtained starting from proton at δ 5.71 (H-9) which correlated with 
signals at δ 2.29 and 2.55 (H2-10), 1.92 (H-11), 2.15 (H-12), 1.97 (H-18), 
0.88 (H-19), and 0.95 (H-20). Moreover, ring B was connected with rings A 
and C by HMBC correlations: H-2/ C-4, C-7, C-11; Me-15/C-3, C-11, C-
14; H-9/C-7, C-11, C-17, C-12, H-6/C-4, C-5, C-8; H-18/C-11, and C-20. 
Analysis of its NMR data revealed signals which matched very closely those 
obtained for compound 10. Comparative analysis of the NMR data of 
compound 13 with diterpene 10 showed close similarities, a point of 
difference was the presence of an acetyl group. Since the proton and carbon 
signals of the –CHOH at C-14 were typically shifted downfield (δH 4.72 ; 
δC 82.0) with respect to  compound 10 the C-14 position must be esterified 
by the acetyl group. The position of the acetyl residue was confirmed by the 
results of the HMBC spectrum of 13 which showed clear long-range 
correlation peaks between the carbonyl carbon signal of acetyl group 
(δ171.00) and the proton signal of CHOH at C-14. 
The relative stereochemistry was elucidated from the ROESY spectrum to 
be identical to that of 10. Therefore, the structure of 13 was defined as 14-
acetyl-Hypoestanonol H. 
 
Fig. 2.8 NMR spectra of compound 13 
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Tab. 2.2: 1H and 13C NMR data of compounds 1–2 (CD3OD, 600 MHz, J in Hz)a 
Compounds 
Position  1  2 
  δH δC  δH δC 
1  - 35.0  - 36.0 
2 a 
2 b 
 2.69 d (9.0) 
1.68 d (9.0) 
40.8  1.71 d (14.5) 
1.53 d (14.5) 
42.1 
3  - 125.4  - 63.4 
4  - 126.0  - 69.4 
5  2.33 m 37.8  1,98 dd (11, 7.7) 
1.68 m 
33.0 
6 a 
6 b 
 1.94 m 
1.84 m 
23.9  1.50 a 
1.38 m 
21.4 
7  2.58 dd (6.5, 6.0) 52.6  3.18 dd (6.63,10) 
 
43.8 
8  - 57.4  - 131.0 
9  2.88 m 65.0  5.68 t (8) 124.4 
10 a 
10 b 
 2.24 ddd (8.0,11.0,14.0) 
1.39 o 
25.6  2.14 br dd(14, 8) 
2.20 br dd(14, 7) 
24.7 
11  1.85 br dd (7.4, 11.3) 50.8  1.69dd (12, 7.5) 56.6 
12  2.30 m 48.5  2.23m 49.0 
13 a 
13 b 
 1.65 m 
1.52 o 
23.7  1.59 o 
1.51o 
23.7 
14 a 
14 b 
 1.51 o 
1.44 m 
43.9  1.59 o 
1.48 o 
44.3 
15  0.67 s 18.4  0.95 s 18.7 
16  1.67 s 13.9  1.36 s 16.0 
17  1.12 s 17.8  1.66 s 20.0 
18  1.90 m 29.6  1.90 m 29.6 
19  0.80 d (6.8) 19.6  0.84 d (6.8) 20.5 
20  0.94 d (6.8) 23.3  0.92 d (6.8) 23.8 
 
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments 
o. Overlapped signal
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Tab. 2.3 1H and 13C NMR data of compounds 10–13(CD3OD, 600 MHz, J in Hz)a 
Compounds 
Position  10  13 
  δH δC  δH δC 
1  - 48.0  - 46.9 
2a 
2b 
 3.18 d (8.7) 
1.89 d (8.7) 
39.5  2.90 d (9.3) 
2.01 d (9.3) 
39.5 
3  - 178.8 - 177.4 
4  - 138.6 - 146.2 
5  - 213.0 - 212.2 
6  2.49 m 
1.80 m 
38.0  2.48 o 37.9 
7  4.15 br t (6.5) 44.0  4.12 br d (6.5) 44.1 
8  - 135.0 - 135.5 
9  5.73 m 130.0 5.71 128.7 
10a 
10b 
 2.54 ddd (9.3,14.0,5.0) 
2.26 m 
24.8  2.55 o 
2.29 o 
24.7 
11  1.83 br dd (11.5,7.0) 54.1  1.92 m 53.4 
12  2.07 m 43.8  2.15 44.6 
13a 
13b 
 1.94 m 
1.47 m 
32.3  2.18 
1.45 
27.9 
14  3.69 dd (10.5,5.5) 80.0  4.72 br s 82.0 
15  0.83 s 13.3  0.96 s 14.0 
16  1.72 s 8.62  1.70 s 6.7 
17  1.52 s 18.0  1.51 s 18.3 
18  1.95 m 29.4  1.97 28.2 
19  0.88 d (7.0) 20.6  0.88 d (6.8) 20.4 
20  0.95 d (7.0) 23.8  0.95 d (6.8) 24.6 
    CH3CO - 171.0 
    CH3CO 2.10 s 20.9 
 
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC 
experiments. 
o. Overlapped signal
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Known compounds isolated from H. forskaolii leaves 
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Fig. 2.9 Known compounds of H. forskaolii 
 
2.7  Discussion 
GIN are a major cause of disease in grazing sheep. Despite the progress in 
the development of parasite vaccines, anthelmintic are still indispensable for 
the for worm treatment and control (Molento et al., 2011). However, the 
indiscriminate use of anthelmintic to control helminths has led to a widely 
AR in sheep (Jackson et al., 2012). The development of AR to commercially 
available drugs as well as the risks that are associated with the presence of 
these products in the environment and in foods of animal origin have 
encouraged the search for new active ingredients that are less toxic, able to 
minimize the presence of drug residues in food of animal origin and more 
efficient. 
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In this context, products of plant origin may be an effective alternative for 
the control of parasites (Nery et al., 2009). The use of plants with 
anthelmintic properties is considered as one of the most viable alternative 
methods for the control of GINs even though crude drugs are less efficient 
with respect to cure of diseases but are relatively free from side effects. 
A large number of medicinal plants could possess anthelmintic properties in 
the traditional system of medicine and are also used by ethnic groups in the 
world, unfortunately, only a small number of plant species shows an 
appreciable ovicidal activity (Mali and Mehta, 2008). 
The results of this study show that extracts from the leaves of H. forskaolii 
exhibit a weak ovicidal activity against GIN, whereas only two works have 
succeeded in demonstrating that two plants, belonging to Acanthaceae 
family, show a considerable in vitro ovicidal activity, but only within their 
polar residues, such as aqueous and ethanolic. Nevertheless, there are no 
studies which focus on apolar extracts such as the n-hexane and the 
chloroformic. In a study by (Al-shaibani et al., 2008), the aqueous and 
ethanolic extracts of Adhatoda vasica presented ovicidal activity against the 
GIN eggs. The ethanolic extract was slightly more effective compared to 
aqueous extract on eggs. In the study of (Adamu et al., 2010) it was instead 
taken into account only the aqueous extract of Acanthus montanus (Nees) T. 
Anders (Acanthaceae). In this work, in addition to polar methanolic extract, 
the apolar and medium polar residues, respectively the n-hexane, 
chloroform and chloroform methanol 9: 1, were analyzed for the first time 
in a plant belonging to the Acanthaceae family. 
In conclusion, in the adopted experimental conditions, the n-hexane extract 
showed a rather mild egg hatch inhibition and a dose-dependent effect on 
nematode eggs hatching while on the contrary in other studies, conducted in 
various experimental conditions, the n-hexane extract and other apolar 
extracts from different plant species showed dissimilar ovicidal activities 
against nematodes in sheep, such as H. contortus, Teladorsagia spp., 
Trichostrongylus spp., Strongyloides papillosus, Oe. columbianum, 
Chabertia ovina (Assis et al., 2003; Devi Rajeswari, 2014; Maciel et al., 
2006). 
According to the adopted experimental approach, it was not possible to test 
the extracts in concentrations higher than 1mg/ml because of the turbidity 
of the solutions created in wells during the EHA. Despite using surfactant 
substances to increase the solubility of the extracts, it was impossible to 
count the eggs or larvae in those wells where concentrations exceeded the 
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highest cited. Moreover, limited to the chloroform:methanol 9:1extract, it 
was impossible to analyse the concentration of 1mg/ml due to the turbidity 
of the solution that was to already created at that concentration. 
The inhibition of egg hatch in vitro is an indication of the possible usefulness 
of various plant as potential anthelminthic and, in Particular, H. forskaolii 
appears to possess a dose-dependent anthelmintic activity with a mild 
activity shown. For these reasons, under our experimental conditions we 
have obtained encouraging results and extracts of this plant can be tested on 
other species of helminths and it could be interesting to evaluate the efficacy 
of n-hexane extracts of the other plants of Acanthaceae family in order to 
study their activity, toxicity, mechanism of action, identification of 
phytochemicals. 
Finally, the phytochemical study of n-hexane extract led to the isolation of 
several pure compounds which they have not been tested yet because of the 
very few amounts. Hence, the antiproliferative potential of the all isolated 
compounds was tested in vitro. Exponentially growing cultures of HeLa 
(cervical carcinoma) and Jurkat (T-cell leukemia) cells were exposed to 
increased concentrations of all isolates and cell viability was evaluated at 48 
h by MTT assay. All tested compounds did not affect significantly cell 
growth and viability.  
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3.1 Meliaceae family 
The Meliaceae family, belonging to the order Rutales, is split in four 
subfamilies: Swietenioideae, Melioideae, Quivisianthoideae and 
Capuronianthoideae (Salles, 1995). This family classified 51 genera 
containing about 1400 species of the tropics and subtropics in both 
hemispheres (Banerji and Nigam, 1984). Plants of this genus present great 
economic interest by the wood and essential oils industries (Mosqueta, 
1995; Penington, 1981). Meliaceae are a widely distributed in subtropical 
and tropical angiosperm family occurring in a variety of habitats, from rain 
forests and mangrove swamps to semi deserts areas (Pérez-Flores et al., 
2012). The major specialized metabolites of Meliaceace family are 
limonoids (tetranortriterpenoids) and terpenoids even though alkaloids, 
flavonoids and phenolic compounds are also present in remarkable amount. 
Many biological activities have been reported for the species belonging to 
Meliaceae family such as antimicrobial activity (Ragasa et al., 2014; Fang 
et al., 2009; Irungu et al., 2014), cytotoxicity against many tumour cell lines 
and uterotonic activity. These interesting activities suggest that chemical 
studies and biological screenings of small molecules of Meliaceae family 
are needed. (Kaur and Arora, 2009; Rashed, 2014; Yang et al., 2012) 
3.2 Trichilia Genus 
The Trichilia genus is composed by 70 species, mainly present in tropical 
America and Africa, of which 43 species occur in Brazil (del Carmen 
Ramı́rez et al., 2000; Pupo et al., 2002). Trichilia is a genus which has the 
largest number of species in Meliaceae. (Patrício and Cervi, 2005; Rocha, 
2010). A significant number of reports showed biological and 
pharmacological activities of crude extracts and pure secondary metabolites 
isolated from different parts of plants belonging to Trichilia genus. The main 
biological activity is antibacterial activity against plant parasites, and 
bactericide activity against Bacillus cereus, Eschericha coli, Pseudomonas 
aeruginosa and Staphylococcus aureus; cytotoxic and antioxidant activities 
are also reported for this genus (del Carmen Ramı́rez et al., 2000; Jolad et 
al., 1981; Kubo and Klocke, 1982; Pizzolatti et al., 2002; Tang et al., 2007). 
The crude extracts of T. catigua (A. Juss.), T. connaroides (Wight & Am.) 
Bentv., T. elegans a. juss, showed antiplasmodium and insecticidal activity 
(Agripino et al., 2004; Kumar et al., 2011; Matos et al., 2009). The ethyl 
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acetate extract of aerial parts of T. quadrijuga (Miq.) Kunth showed high 
antibacterial activity against S. aureus and S. epidermidis (Rodrigues et al., 
2009), while the aqueous leaves extract of T. glabra L. was found to possess 
anti-inflammatory effect (Benencia et al., 2000). 
3.2.1 Previous phytochemical studies on Trichilia genus 
Chemical composition of Trichilia species revealed the presence of 
secondary metabolites from the metabolic pathway of terpenoids. 
Particularly limonoids, nor-triterpenes with high oxygenation, appear to be 
the major chemosystematics markers of the Meliaceae family (Lagos, 2006; 
Rodrigues et al., 2009). The secondary metabolites isolated from the genus 
Trichilia are shown below. 
3.2.1.1 Monoterpenes 
6 monoterpenes were identified in the Trichilia genus (Fig.3.1) (Kumar et 
al., 2011; Amaro, 2007). 
 
  
β-cyclocitral 
T. connaroides leaves 
azulene 
T connaroides 
leaves, roots, stem 
naphthalene 
T. pallida Sw. leaves 
 
 
 
 
cis-ocimene 
T. connaroides 
leaves, roots, stem 
eucalyptol 
T. connaroides 
leaves, roots 
 
Cuminol 
T. connaroides 
leaves and 
wood 
2-methyl-2-
bornene 
T. connaroides 
leaves and wood 
Fig. 3.1 Monoterpenes of Trichilia genus 
3.2.1.2 Sesquiterpenes 
57 sesquiterpenes were identified in the Trichilia genus, revealing various 
skeletons, (Aladesanmi and Odediran, 2000; Amaro, 2007; Kumar et al., 
2011) (Fig..3.2). 
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cryptomeridiol 
T. connaroides 
wood 
mustacone 
T. silvatica 
leaves 
10-epi-γ-eudesmol 
T.pallida leaves 
α-humulene 
T. pallida 
leaves 
    
β-gurjunene 
T. connaroides 
wood 
germacrane D 
T. connaroides 
stem and wood 
β-cedrene 
T. connaroides 
wood 
i-longipinene 
T. connaroides 
roots 
Fig. 3.2 Sesquiterpenes of Trichilia genus 
3.2.1.3 Diterpenes 
7 diterpenes were identified in the Trichilia genus (Aladesanmi and 
Odediran, 2000; del Carmen Ramı́rez et al., 2000) (Fig.3.3). 
 
  
(1R,3E,7Z,11S,12S)-
dolabella-3,7,18-trien-17-
oic acid 
T. heudelotii (Th) leaves 
(1R,3E,6R,7Z,11S,12S)-
dolabella-3,7,18-trien-6,17-
olide 
T. trifolia (A.Juss.) stem 
(1R,3S,4R,7Z,11S,12S)-3-
hydroxydolabella-7,18-dien-4,17-olide 
T. trifolia stem 
 
R=CH3 nimbiol;R=C3H7 7-
ketoferruginol 
T. heudelotii leaves 
 
Isopimarinol 
T. heudellotti leaves 
 
12β-hydroxysandaracopimar-15-
ene  
T. heudellotti leaves 
Fig. 3.3 Diterpenes of Trichilia genus 
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3.2.1.4 Triterpenes  
57 triterpenes were identified in Trichilia of which 32 tetracyclic triterpenes, 
fourteen cycloartane-type, four triterpenes with A-seco-ring and seven pentacyclic 
triterpenes (Inada et al., 1994; Cortez et al., 1998; Figueiredo, 2010; Garcez et al., 
1996; Rocha, 2010; Ambrozin, 2004) (Fig.3.4). 
  
vellozone 
T. connaroides leaves 
Isofouquerione 
T. estipulate (Wight & Arn.) fruits 
 
 
24-methylen-26-hydroxycicloartan-3-one 
T. casaretti C.DC. leaves 
trichiliol 
T. casaretti leaves 
 
 
methyl-1ξ,7(R)-diacetoxy-23(R),25(S)-
dihydroxy-20(S)-21,25-epoxy-3,4-seco-
apotirucall-4(28), 4(15)-dien-3-oate 
T. elegans seed 
methyl-1(S),23(R)-diacetoxy-7(R),24,25-
trihydroxy-20(S)-21,24-epoxy-3,4-seco-
apotirucall-4(28), 14(15)-dien-3-oate 
T. elegans seed 
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pseudotaraxasterol 
T. sylvatica Kunth leaves 
R1=CH3; R2=H α-amirine 
R1=H; R2=CH3 β-amirine 
T. ramalhoi C.DC. leaves 
Fig. 3.4 Triterpenes of Trichilia genus 
3.2.1.5 Steroids  
A total of 30 steroids were isolated of Trichilia ssp, distributed in the leaves 
and stem of the species T. claussenii and T. connaroides (Fig.3.5) 
  
 
R1=H; R2=OH 
2α,3α-dihydroxyandrostan-
16-one-2β,19-hemiketal 
T. claussenii C.DC. leaves 
(Pupo et al., 2002) 
Trichiliasterone B 
T. americana C. DC. stem 
(Hantos et al., 2001) 
3β,4α-
dihydroxypregnan-21-
one 
T. connaroides stem 
(Wang et al., 2008) 
Fig. 3.5 Steroids of Trichilia genus 
3.2.1.6 Limonoids  
Among all the compounds isolated and identified by phytochemical 
investigation of species of the Trichilia genus, the limonoids represent the 
largest number. 129 limonoid were isolated and characterized from T. 
connaroides, T. emetica, T. havanensis, the last specie revealed the higher 
amount of these compounds (Fig..3.6). 
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Hydroxybutenolide T. havanensis seeds 
(Arenas and Rodriguez-Hahn, 1990) 
dregeana-5 T. dregeana SOND  stem 
(Connolly et al., 1976) 
 
 
trichilin A (235) 
T. catigua seed 
(Hill and Sutherland, 2009) 
trichiconnarin A 286 
T. connaroides leaves 
(Wang et al., 2008) 
Fig. 3.6 Limonoids of Trichilia genus 
3.3 Trichilia maynasia C. DC. 
Trichilia maynasiana C. DC. syn. Trichilia senxanthera, (Meliaceae), 
known with the name of “Sulafinzan” in the language of Bambara, is a tree 
widely distributed in tropical areas and in West-Africa lands. The plant is 
employed for the treatment of various disorders in Mali as purgative, 
antiepileptic, antipyretic and antimalarial agent, bronchial and inflammation 
deseases (Iwu, 1993),while, in South America especially in Venezuela, this 
plant is used in traditional medicine in the treatment of hemorrhoids, 
gastrointestinal disorders and as an antimalarial (Malgras, 1992). 
AIM 
The aim of this work was the isolation and structural characterization of 
secondary metabolites from T. maynasiana and the evaluation of their 
cytotoxic activity. 
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3.4 Experimental 
3.4.1 Plant material 
The leaves of Trichilia maynasiana were collected in Mérida-Venezuela and 
identified by Ing. Juan Carmona. A voucher specimen number (No 011) was 
deposited at the Herbarium MERF. 
3.4.2 Extraction and isolation 
The dried leaves of T. maynasiana (200 g) were powdered and exhaustively 
extracted using n-hexane, CHCl3 and MeOH in an ASE 2000 extractor to 
yield 4.2, 6.2, 3.0 g of the respective residue (Fig..3.7). 
 
Fig. 3.7 Extracts of T. maynasiana leaves 
Part of the n-hexane (3.5 g) extract was separated using silica gel, eluting 
with n-hexane followed by increasing concentrations of CHCl3 in n-hexane 
(between 1% and 100%) and MeOH in CHCl3 (between 1% and 100%). 
Fractions of 25 mL were collected, analysed by TLC and grouped into 11 
fractions (A-K) (Fig..3.8). 
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n-hexane extract
3.5 g
F
la
s
h
 C
C
E
402 mg
C
74 mg
A
20 mg
K
242 mg
I
84.7 mg
G
64. 7 mg
F
196 mg
D
270 mg
B
80 mg
J
164 mg
H
38 mg
 
Fig. 3.8 Separation scheme of n-hexane extract 
Fraction D (270 mg) was subjected to RP-HPLC with CH3OH:H2O (95:5) 
as eluent. The spectroscopic analysis of the resolved peaks, has led to the 
characterization of pure 3β-25-dihydroxytirucalla-7,23-diene (1.2 mg, tR 20 
min); Fraction E (402 mg) was separated by RP-HPLC with CH3OH:H2O 
(9:1) as eluent to give pure spathulenol (1.5 mg, tR 8 min), compound 1 (3.0 
mg, tR 28 min) and 3β-25-dihydroxytirucalla- 7,23-diene (2 mg, tR 32 min); 
Fraction I (84,7 mg) was subjected to RP-HPLC with CH3OH:H2O (17:8) 
as eluent. The spectroscopic analysis of the resolved peaks, has led to the 
characterization of pure aromadendrane-4β,10α-diol (1.0 mg, tR 15 min); 
Fraction J (164 mg) was was separated by RP-HPLC with CH3OH:H2O 
(65:35). The spectroscopic analysis of the resolved peaks, has led to the 
characterization of pure 1,7-azulenediol,1,2,3,3α,4,5,6,7-octahydro-1,4- 
dimethyl-7-(1-methylethyl) (2.9 mg, tR 50 min). 
Part of the CHCl3 extract (5.0 g) was subjected to silica gel column 
chromatography eluting with CHCl3, followed by increasing concentrations 
of MeOH in CHCl3 (between 1% and 100%). Fractions of 25 mL were 
collected, analysed by TLC using as mobile phase a solution of n-
BuOH:AcOH:H2O (60:15:25) and CHCl3:CH3OH:H2O (80:18:2) sprayed 
with a Ce(SO4)2 (10% H2SO4) reagent and grouped into 13 fractions (Aa-
Mm) (Fig..3.9). 
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Fig. 3.9 Separation scheme of chloroformic extract 
Fraction Dd (610 mg) was chromatographed over RP-HPLC with 
CH3OH:H2O (95:5) as eluent to give pure butyrospermol (8.0 mg, tR 40 
min); Fraction Ee (1800 mg) was subjected to RP-HPLC with CH3OH:H2O 
(85:15) as eluent to give pure compound 1 (1.6 mg, tR 65 min), 3β-25- 
dihydroxytirucalla-7,23-diene (8.0 mg, tR 72 min) and masticadienediol (2.2 
mg, tR 90 min); Fraction Hh (296,2 mg) was chromatographed over RP-
HPLC with CH3OH:H2O (31:19) as eluent to give pure compound 2 (1.1 
mg, tR 10 min) and aromadendrane-4β,10α- diol (1.6 mg, tR 18 min); 
Fraction Ii (124,8 mg) was subjected to RP-HPLC with CH3OH:H2O 
(35:15) as eluent. The spectroscopic analysis of the resolved peaks, has led 
to the characterization of pure lochmolin f (1.2 mg, tR 11 min) and 1,7-
azulenediol. 
3.4.3 Analysis of sulfate group 
Briefly, a 1 mg aliquot of compound 1 was refluxed with 10% HCl (4 mL) for 4 h 
and extracted with Et2O. An aliquot of the aqueous layer was treated with 70% 
BaCl2 to give a white precipitate (BaSO4). 
 
 
Chloroform  extract
5 g
F
la
s
h
 C
C
Ff
120 mg
Bb
150 mg
Ll
50.0 mg
Jj
170.5 mg
Hh
280 mg
Ee
1.5 g 
Cc
230 mg
Aa
554 mg
Ii
125.0 mg
Gg
160 mg
Mm
75.0 mg
Kk
132.0 mg
Dd
582 mg
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3.4.3.1 Compound 1 
Amorphous white powder; 25D : -26.2 (c 0.13, MeOH); for 1H and 13C 
NMR spectroscopic data see Tab. 3.1; ESIMS m/z: 523 [M + H]+, 443 [(M 
+H) –80], HRESIMS m/z: 523.3440 [M+H]+ (calcd for C30H50O5S, 
522.3379). 
3.4.3.2 Compound 2 
Amorphous white powder;  25D : +46.7 (c 0.11, MeOH); for 1H and 13C 
NMR spectroscopic data see Tab. 3.1; ESIMS m/z: 253 [M + H]+ HRESIMS 
m/z: 253.1795 [M+H]+ (calcd for C15H24O3, 252,1725). 
 
3.4.4. Cells and treatment 
HeLa (cervical carcinoma), and Jurkat (T-cell leukemia), and cell lines were 
obtained from the American Type Cell Culture (ATCC) (Rockville, MD, 
USA). Cells were maintained in DMEM (HeLa) or RPMI 1640 (Jurkat and 
U937), supplemented with 10% FBS, 100 mg/L streptomycin and penicillin 
100 IU/mL at 37 °C in a humidified atmosphere of 5% CO2. To ensure 
logarithmic growth, cells were subcultured every two days. Stock solutions 
(50 mM) of purified compounds in DMSO were stored in the dark at 4 °C. 
Appropriate dilutions were prepared in culture medium immediately prior 
to use. In all experiments, the final concentration of DMSO did not exceed 
0.15% (v/v). 
3.4.5. Cell viability and cell cycle  
Cells were seeded in 96-well plates and incubated for the established times 
in the absence (vehicle only) and in the presence of different concentrations 
of compounds and Etoposide as positive control. The day before treatments, 
cells were seeded at a cell density of 1×104 cells/well. The number of viable 
cells was quantified by MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide]) assay. Absorption at 550 nm for each well 
was assessed using a microplate reader (LabSystems, Vienna, VA, USA). In 
some experiments cell viability was also checked by Trypan Blue exclusion 
assay using a Bürker counting chamber. IC50 values were calculated from 
cell viability dose – response curves and defined as the concentration 
resulting in 50% inhibition in cell survival as compared to controls. Cell 
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cycle was evaluated by propidium iodide (PI) staining of permeabilized cells 
according to the available protocol and flow cytometry (BD FACSCalibur 
flow cytometer, Becton Dickinson, San Jose, CA, USA). Data from 5000 
events per sample were collected. The percentages of the elements in the 
hypodiploid region and in G0/G1, S and G2/M phases of the cell cycle were 
calculated using the CellQuest or MODFIT software, respectively. 
3.4.6. Statistical analysis 
Data reported are the mean values ± SD from at least three experiments, 
performed in duplicate, showing similar results. Differences between 
treatment groups were analyzed by Student’s t-test. Differences were 
considered significant when p < 0.05. 
 
3.5 Result and discussion 
The purification process led to isolation of 9 natural compounds, of which 2 
are new molecules. The structural characterization of all the secondary 
metabolites isolated from the aerial parts of T. maynasiana were achieved 
by using different spectroscopic techniques (NMR, MS, UV). 
NMR and MS data of compound 1 demonstrated the molecular formula 
C30H48O4S (HRESIMS at m/z 523, 3440 [M+H]
+), which suggested the 
presence of a sulphate group in the molecule. Acid hydrolysis of compound 
1 followed by treatment with BaCl2, confirmed the presence of a sulphate 
group. 
The ESI-MS in positive ion mode showed the [M+H]+ ion peak at m/z 523, 
and fragments by MSn analysis at m/z 443 [M+H-80]+ corresponding to the 
loss of the sulphate group. This information, along with the 13C NMR 
spectrum allowed the determination of seven double bond equivalents. 
Resonances consistent with two double bonds (δC 119.0, 146.7, 149.0, and 
113.0) were immediately identifiable from the NMR spectroscopic data of 
compound 1. 
The 1H NMR spectrum of compound 1 demonstrated the presence of five 
tertiary methyls, a vinyl methyl, a secondary methyl, an oxymethine proton 
, and three vinyl protons. 1D TOCSY and COSY spectra suggested the 
presence in the molecule of four spin systems attributable to C-1―C-3, C-
5―C-7, C-9―C-12, and C-15―C-24. Direct evidence of the substituent 
sites was derived from the HSQC and HMBC correlations, which also 
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allowed the assignment of all the resonances in the 13C NMR spectrum. 
Long-range correlations were observed between Me-18 and C-12, C-14, C-
17, between H-17 and C-21, C-16, C-14, and between H-7 and C-9, C-8, C-
14, Me-21 and C-17, C-21, C-22, H- 24 and C-27, C-26, C-23, Me-27 and 
C-25, C-24. The α-orientation of H-9, H-5 and Me-30, and the β-orientation 
of Me-18 and Me-19 were indicated by ROE correlations. These results 
were confirmed these results were confirmed by the chemical shifts of the 
carbons, which matched well with those of the related tirucallane (Makino 
et al., 2004). 
On the basis of these data, compound 1 was characterised as 3β,24-
dihydroxy-tirucalla-7,25-diene, 24-sulfate. 
1 
The 
13
C NMR spectrum of compound 2 showed signals for 15 carbons, 
including two carbonyl groups, one of them α,β unsaturated (δc 146.3, 
152.0, 201.1 and 210.6). The HRESIMS of 2 showed a quasi-molecular ion 
at m/z 253.1799 [M+H]+. From this and 13C NMR data a total of eight 
hydrogen deficiencies were determined, one of which was a ring. The 
chemical shifts of 2 were obtained from the correlations observed in COSY, 
HSQC, and HMBC experiments. The HMBC spectrum showed 
correlations between the methyl signal at δH 2.10 and C-4, C-2; the methyl 
signal δH 1.31 and C-2, C-9: the signal at δH  6.47 and C-5, C-4, C-6, C-10; 
and the signal at δH 2.35 and C-12, C-5, C-8, C-11, which locating the α,β 
unsaturated carbonyl group at C-1,C-2 and C-5, the carbonyl group at C-4, 
and the carbinol group at C-10. The relative stereochemistry of 2 was 
determined by 1D ROESY experiments and comparison with literature data 
(Pereira et al., 2012). Correlations were observed between H-8β at δH 1.90 
and Me-14, H-11β, showing that the Me-14 re in a β position. 
The structure established for 2 was 7-epi-10-hydroxychabrol-1(2)-en-
dione. 
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2 
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Tab. 3.1 1H and 13C NMR data of compounds 1 and 2 (CD3OD, 600 MHz, J in Hz)
a 
Position  1   2  
  δH δC δH δC 
1a 
1b 
 1.18 m 
1.73 m 
37.8  - 146.3 
2a 
2b 
 1.85 m 
1.90 m 
26.8  6.47 152.0 
3  3.28 dd, (4,8, 11,0) 79.0  2.08 37.8 
4  - 40.0  - 210.1 
5  1.33 m 52.0  - 201.6 
6a 
6b 
 2.16 d (8) 
2.01 m 
25.3  2.35 dd (6.0, 12.5) 
2.31 d (12.5) 
42.3 
7  5.31 br s, 119.0  2.38 44.1 
8a 
8a 
 - 
- 
146.7  1.90 m 
1,60 m 
25.6 
9a 
9b 
 2.25 dd (10.0, 5.0) 
- 
50.0  2.47 m 
2.60 m 
36.3 
10  - 36.4  - 69.4 
11  1.58 m 19.4  1.31 s 33.0 
12a 
12b 
 1.48 m 
1.67 m 
35.2  0.79 d (6.5) 
- 
20.9 
13  - 52.2  0.88 d (5.0) 20.5 
14  - 45.0  1.43 s 27,6 
15a 
15b 
 1.83 br d (14.0) 
1.56 m 
35.2 
 
 2.10 s 
- 
29.7 
16a  1.91 br d (6.0) 
1.95 br d (6.0) 
28.00    
17  1.53 m 54.0    
18  0.87 22.0    
19  0.80 13.5    
20  1.43 m 37.0    
21  0.92 d (6.0) 18.8    
22a 
22b 
 1.12 m 
1.45 m 
33.0    
23  1.33 28.0    
24  4.19 d (6.0) 90.0    
25  - 149.0    
26a 
26b 
 4.90 d (10.5) 
4.94 m 
113.0    
27  1.72 br s 17.0    
28  0.88 15.6    
29  0.96 28.0    
30  1.03 27.0    
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments 
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Known compounds of Trichilia maynasia 
Seven known compounds were also identified as 3β-25-dihydroxytirucalla-
7,23-diene (3) (Su et al., 2010), Butyrospermol (4) (Ozen et al., 2008), 1,7-
azulenediol (5) (Baba et al., 2007), Masticadienediol (6) (Luo et al., 2000), 
Spathulenol (7) (Ozen et al., 2008), Lochmolin F (8) (Luo et al., 2000), 
Aromadendrane-4β,10α-diol (9) (Ozen et al., 2008) by detailed NMR and 
MS analyses and compared with literature data as in Fig.. 3.10. 
 
 
3 4 
 
 
5 6 
 
 
 
7 8 9 
Fig. 3.10 Known compounds of T. maynasiana 
 
All the isolates were tested for the antiproliferative activity towards Hela 
and Jurkat, no activiy was observed. 
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4.1 Vernonia genus 
For further information about Asteraceae family see Chapter 1. 
Vernonia (Asteraceae) is the largest genus in the tribe Vernonieae with close 
to 1000 species (Keeley and Jones Jr, 1979). The genus Vernonia is named 
after William Vernon, an English botanist who collected and identified this 
genus in Maryland (Quattrocchi, 1999). The genus is distributed both in the 
New and Old World although it is to be found mostly in the tropical regions. 
Vernonia species grow in a wide range of habitats of broad ecological 
diversity and climatic conditions including tropical forest, marshes and wet 
areas, dry plains, tropical savannahs and even frosty regions of eastern North 
America (Gleason, 1923; Keeley and Jones Jr, 1979). In regard to chemical 
diversity, plants of the Vernonia genus are the source of many terpene type 
compounds particularly sesquiterpenes, steroids and their glycosides 
(Django et al., 2007; Huffman and Seifu, 1989; Mølgaard et al., 2001; Yeap 
et al., 2010). Plants this genus are widely used in ethnomedicine, 
ethnoveterinary medicine and in zoopharmacognosy particularly by 
chimpanzees and gorillas. A total of 109 species of Vernonia are reported to 
be used in folk medicine. Vernonia genus are used in ethnoveterinary 
medicine as anthelmintic, hepatoprotective and insecticidal (Burkill, 
1985; Yineger and Yewhalaw, 2007; Regassa, 2000; Hussain et al., 2008; 
Githiori et al., 2006). 
 
4.1.1 Vernonia genus: phytochemistry bioactive compounds 
4.1.1.1 Phenols compounds 
Flavonoids are among the two major classes of compounds encountered in 
the Vernonia genus (Carvalho et al., 1999). Most of the ﬂavones and 
phenolic compounds have been isolated from Vernonia amygdalina Delile 
and Vernonia cinereal Less. and have exhibited potent antioxidant as well 
as urease inhibitory activity (Ahmad et al., 2011; Igile et al., 1994; 
Abeysekera et al., 1999) (Fig..4.1). 
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Luteolin Methyl caffeate Gallic acid 
 
Fig. 4.1 Main phenols of Vernonia ssp 
 
4.1.1.2 Terpenoids 
 
Terpenoids are the largest known class of secondary metabolites in plants 
(Harborne, 1999). They play a role in interaction of plants with their 
environment and terpenoids have been shown to have a broad range of 
biological activities such as antibiotic, cytotoxic, antimalarial, antifeedant, 
insecticidal, moluscidal and herbicidal (Zhang et al., 2005; Roberts, 2007; 
Gershenzon and Dudareva, 2007; Kaur et al., 2009). Among plants of the 
Vernonia genus so far studied for biological activity, a number of the 
reported biological activities have been associated with the presence of 
terpenoids. In Fig..4.2 some terpenoids isolated from Vernonia genus are 
shown. 
 
 
 
  
Vernonione 
Urease inhibitor 
(Ahmad et al., 2012) 
α-amirina 
Antibacterial activity 
(Kiplimo et al., 2011) 
Lupeol 
Antiplasmodial 
(de Almeida Alves et al., 1997) 
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Vernodalol 
Antifungal 
(Erasto et al., 2006), 
Vernolide 
Antibacterial, Antifungal 
(Erasto et al., 2006) 
Zaluzanin D 
Antifungal 
(Kumari et al., 2003) 
 
Fig. 4.2 Terpenoids of Vernonia genus 
 
4.1.2 Vernonia nigritiana Oliv. & Hiern 
 
Vernonia nigritiana Oliv. & Hiern. (Asteraceae) Synonyms: Cacalia 
nigritana Kuntze; Linzia nigritiana (Oliv. & Hiern) Isawumi is an annual 
herb or shrub widely distributed in West Africa, where the leaves and other 
parts of the plant are traditionally used against skin inflammations and 
infections, rheumatism, fever, headache and digestive insufficiency (Johri 
and Singh, 1997; Toyang and Verpoorte, 2013). 
Burkill (1985) isolated a bitter monoterpene glycoside (Vernonin) from the 
roots of V. nigritiana. Vernonin showed a digitalis (digoxin) like action on 
the heart but it is weaker than digoxin. 
Vassallo et al. (2013) reported the topical anti-inflammatory properties of 
apolar extracts of V. nigritiana leaves, supporting the use in the West 
African traditional medicine for the treatment of inflammatory diseases. 
Phytochemical investigation of the Vernonia nigritiana leaves extracts led 
to the isolation of nine new polyhydroxylated stigmasterol glycosides (1–9) 
and six new stigmastanes (10–15) with different potency as anti-
inflammatory agents (Fig..4.3). 
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6 β-D-Glc 15 H 8 β -D-Glc 9 β -D-Glc 
 
Fig. 4.3 Structures of compounds 1–15 isolated from Vernonia nigritiana 
 
AIM 
In the present study, a phytochemical and pharmacological investigation of 
V. nigritiana leaves extracts was carried out to identify the relevant active 
principles. 
4.2 Experimental 
4.2.1 Plant materials 
The leaves of V. nigritiana were collected in 2012 from the Bougouni, 
Sikasso region of Mali, near Bandiagara,. The plant material was identified 
 R R1 R2 R3 
1 β-D-Glc OH OH CH2OH 
2 β -D-Glc H OH CH3 
3 β -D-Glc OH OH CH3 
4 β -D-Glc =O OH CH2OH 
5 β -D-Glc =O OH CH3 
7 β -D-Glc H OH CH2OH 
10 H =O OH CH2OH 
11 H OH OH CH3 
12 H H H CH2OH 
13 H =O H CH3 
14 H OH OH CH2OH 
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by Prof. Rokia Sanogo of DMT, where a voucher specimen was deposited 
(voucher number 1396). 
4.2.2 Extraction and isolation 
The leaves of Vernonia nigritiana (300 g) were dried at 40°C carefully grinded 
and extracted using increasing polarity solvent light petroleum, chloroform, 
chloroform/ methanol (9:1 v/v) and methanol by extensive maceration (3 times 
x 2 L) the solvent was evaporated under vacuum system obtaining the 
following yields 2.0, 5.7, 2.4, 9.0 respectively (Fig..4.4). 
 
 
Fig. 4.4 Percentages and grams of extract obtained from V. nigritiana leaves 
Part of the CHCl3 extract (4.0 g) was separated by silica gel column 
chromatography (CC) eluting with CHCl3, followed by increasing 
concentrations of MeOH (between 1% and 100%). Fractions of 25ml were 
collected, analysed by TLC and grouped into 9 fractions (A-I) (Fig.. 4.5). 
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Fig. 4.5 Scheme of silica gel column of chloroformic extract 
The fraction G was subjected to RP-HPLC with CH3OH:H2O (65:35) as 
eluent. The spectroscopic analysis of the resolved peaks, has led to the 
characterization of pure Glaucolide G (5 mg, tR 37 min) and Glaucolide A 
(2 mg, tR 41 min); fraction H was separated by RP-HPLC with CH3OH: H2O 
(7:3) as eluent to give pure 8α-(4-2 hydroxytigloyloxy)-hirsutinolide (2 mg, 
tR 41 min). 
Part of the CHCl3/MeOH (9:1) extract (2.0 g) was separated by Sephadex 
LH- 20 with MeOH as eluent. Fractions of 10 mL were collected, analyzed 
by TLC and grouped into 10 fractions (A–L). Fraction D (500 mg) was 
separated by silica gel CC eluting with CHCl3 followed by increasing 
concentrations of MeOH (between 1% and 100%). Fractions of 5 mL were 
collected, analyzed by TLC and grouped into 14 fractions (Fig..4.6). 
The fraction Kk (43mg) was subjected to RP-HPLC with CH3OH:H2O 
(29:16) as eluent to give pure compound 1 (1.4 mg, tR 5min). Fraction Ll 
(26mg) was chromatographed over RP-HPLC and eluted with CH3OH: H2O 
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(1:1) to give of pure vernolide-A (0.8 mg, tR 8 min) and vernolide-C (1 mg, 
tR 12 min). Fraction Mm (72mg) was subjected to RP-HPLC with 
CH3OH:H2O (1:1) as eluent to give pure compound 2 (1.8 mg, tR 15 min). 
 
 
 
 
Fig. 4.6 Scheme of silica gel column of chloroform:methanol 9:1 extract 
4.2.2.1 Compound 1 
Amorphous white powder  25D : +26.2 (c 0.13, MeOH); for 1H and 13C 
NMR spectroscopic data, see Tab. 4.1; ESIMS m/z: 409 [M+H]+; HRESIMS 
m/z: 409.1854 [M+H] (calcd for C21H28O8: 408.1784). 
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4.2.2.2 Compound 2 
Amorphous white powder  25D : +33.4 (c 0.11, MeOH); for 1H and 13C 
NMR spectroscopic data, see Tab. 4.1; ESIMS m/z: 423 [M + 
H]+;HRESIMS m/z: 423.2011 [M+H]+ (calcd for C22H30O8: 422.1941). 
 
4.3 Results and discussion 
The purification process led to isolation of 7 natural compounds, of which 2 
are never isolated molecules. Their structural characterization was obtained 
on the basis of extensive NMR spectroscopic and mass spectrometric 
studies. 
Compound 1 was assigned the molecular formula C21H28O8 from 
13
C, 
13
C 
DEPT NMR, and HRESIMS data. The ESI-MS in positive ion mode showed 
the [M+H]
+ ion peak at m/z 409, and fragments at m/z 349 [M+H-60]
+
 
corresponding to the loss of an acetyl group, and m/z 263 [M+H-60-86]
+ 
corresponding to the subsequent loss of esterified groups. The 
13
C NMR 
spectra indicated that compound 1 contained two CH3, three CH2, and two 
CH carbons, as well as three hydroxymethylenes, two hydroxymethines, six 
sp2 carbons, and three ester functionalities. The features of the NMR spectra 
suggested a germacrane skeleton with two tetra-substituted double bonds at 
Δ
1(10) and Δ
4(5)
. From two pairs of doublets and one singlet at δH 4.73 (1H, 
br d, J = 13.5 Hz), 4.59 (1H, d, J = 13.5 Hz), 4.13 (1H, br d, J = 14.0 Hz), 
4.11 (1H, br d, J = 14.0 Hz), and 4.31 (2H, s) three hydroxymethyl groups 
were evident. The presence of a 4-hydroxymethacryloyl group at C-8 was 
deduced from the signals at δH 6.30 (s) and 5.95 (s) for H2-3’ and δH 4.31 
(br s) for H-4’, while the presence of an acetyl moiety was deduced from the 
signals at δH 2.09 (s). Results obtained from 1D TOCSY and COSY 
experiments established the correlations of all protons in compound 1, 
showing the sequences H-1__H-3, H-5__H-9 and H-5__H-13. 
The 13C NMR spectrum was assigned on the basis of a HSQC experiment. 
The location of the 4-hydroxymethacryloyl group, the acetyl group, the 
hydroxymethylene moiety, and the lactone ring were confirmed by the key 
peaks observed in the HMBC spectrum. The signal of H-1 correlated with 
C-19, C-3, C-14; H-5 with C-15, C-3, C-6, C-7; H-8 with C-10, C-1’, C-11; 
and H-6 with C-11, C-4, and C-8. 1D ROESY measurements supported the 
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proposed structure and allowed the relative stereochemistry at C-8, C-6, and 
C-11. Irradiation of H-6 affected H-8, H-11 and H-3β signals, while 
irradiation of H-7 influenced the H-13 and H-9α signals. Consequently, 
compound 1 was established as 8α-(4-hydroxy-methacryloyl)-14-acethoxy-
salonitenolide. 
1 
The 13C NMR spectrum of compound 2 showed signals for 22 carbons, 
including three ester groups. The HRESIMS of 2 showed a quasi-molecular 
ion at m/z 423.2011 [M+H]+. This information, along with the 13C NMR 
spectra, which sorted the 22 carbons into three methyls, six methylenes, 
seven methines, and six quaternary carbons, allowed the determination of 
eight double bond equivalents, two of which was a ring. 1D TOCSY and 
COSY spectra suggested the presence in the molecule of three spin systems 
attributable to C-1__C-3, C-5__C-9, and C-3’__C-5’. Also, for this compound, 
the features of the NMR data suggested a germacrane ring similar to that of 
compound 1 except for the acyl moiety linked at C-8. This was deduced 
from the position and pattern of the H-8 signal at δH 5.56 (br ddd 11.0, 9.4 
and 2.0), and was characterized by the presence of a methyl doublet at δH 
1.92, which was coupled with a quintet of a methine group (δH 6.96), and a 
hydroxymethyl moiety (δH 4.25). The chemical shift and the pattern of this 
signal, according to HSQC results, suggested the presence of a 2-
hydroxymethyl 2-butenoyl group. The HMBC spectrum showed 
correlations between the hydroxymethyl signal at δH 4.73 and C-1, C-9 and 
C-1’; between the signal at δH 4.91 and C-3, C-7, C-15: between the signal 
at δH 5.51 and C-10, C-6, C-9, C-1’; and between the signal at δH 2.84 and 
C-12, C-13, C-9, C-5, locating the lactone group at C-6, C-7, the acetyl 
group at C-14, and the 2- hydroxymethyl 2-butenoyl group at C-8. The 
relative stereochemistry of 2 was determined by 1D ROESY experiments 
and comparison with literature data (Kuo et al., 2003; Youn et al., 2014). 
Significant correlations were observed between H-8 and H-6, and H-11 
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showing that the Me-13 group and 2-hydroxymethyl 2-butenoyl group at C-
8 were in were in the α position. 
The structure established for compound 2 is 8α-(2-hydroxymethyl 2-
butenoyl)-14-acetoxy-salonitenolide. 
 
 
 
2
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Tab. 4.1 1H and 13C NMR data of compounds 1–2 (CD3OD, 600 MHz, J in Hz)a 
  Compounds 
Position  1   2  
  δH δC  δH δC 
1  5.17dd (10.0, 5.0) 135,0  5.17dd (10.0, 5.2) 135,0 
1’   165,9   167,7 
2 
 2.27m 
2.32m 
27,7  2.27m 
2.32m 
27,7 
2’   141,0   133,0 
3 
 2.11ddd (12.0, 11.6 ,6.4) 
2,58ddd (11.0, 4.4, 2.4) 
35,9 
 2,11ddd (12.0, 11.6 ,6.4) 
2,58ddd (11.0, 4.4 2.4) 
35,9 
3’ 
 5,95s 
6,30s 
125,9 
 
6,96q (7.0) 142,2 
4   140,0   140,0 
4’  4.31 s 61,6  1.92 d (7.0) 15 
5  4,91br d (9.0)   4.93br d (9.0) 130,3 
5’   130,3  4,25 br s 59,2 
6  5.34dd (9.0, 8.7) 77,4  5,34dd (9.0, 8.7) 77,4 
7  2.82m 54,0  2.84m 54,0 
8  5.51br ddd (11.0 8.4, 2.4) 73,0  5.56 ddd (11.0, 9.4, 2.0) 73,0 
9 
 2.37br dd (12.6 10.5) 
2,95br d (10.5) 
45,2  2.38br dd (12.6, 10.5) 
2.95br d (10.5) 
45,2 
10   132,7   132,7 
11  2.87m 41,0  2.88m 41,0 
12   181,0   181,0 
13  1.32d (6.2) 10,05  1.34d (6.5) 10,5 
14 
 4.59d (13.5) 
4.73d (13.5) 
63,0  4.60d (13.5) 
4.73d (13.5) 
63,0 
15 
 4.11br d (14.0) 
4.13br d (14.0) 
61,4  4.13br d (14.0) 
4.14br d (14.0) 
61,4 
COMe  2.09 21,0  2.07s 21,0 
COMe   172,0   172,0 
a Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
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Known compounds of Vernonia nigritiana 
The seven known compounds were identified as Glaucolide A (3) 
(Padolina et al., 1974), Glaucolide G (4) (Youn et al., 2014), 8α-(4-
hydroxytigloyloxy)-hirsutinolide (5) (Youn et al., 2014), Vernolide-A (6) 
(Kuo et al., 2003), Vernolide-B (7) (Kuo et al., 2003), by detailed NMR 
and MS analyses and compared with literature data as in Fig.. 4.7. 
 
 
3 4 
 
 
5 6 
 
7 
Fig. 4.7 Compounds of V. nigritiana 
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5.1 Chromatographic techniques 
5.1.1 Thin Layer Chromatography 
TLC (Thin Layer Chromatography) was performed on precoated Kieselgel 
60 F254 plates (Merck), 0.25 mm thick, with glass or aluminium as support. 
The spots were revealed using UV detection with lamp at 254 or 366 nm 
and successively using specific spray reagents, allowing to the development 
of typical colouring that can give information about the nature of examined 
compounds. Ce2S04/H2S04: it is a general reactive used to reveal all 
compounds contained in mixtures; it can also give specific information, for 
example triterpenes give typically violet spots. It is a saturated solution of 
cerium sulphate in 65% sulphuric acid. Heating at 120 °C for 15 min is 
needed to reveal the spots. 
As eluting solvents in the TLC analyses, two mixtures of solvents were 
mainly used: 
• CHCl3-MeOH-H2O (80:18:2) for apolar mixtures 
• n-BuOH-AcOH- H2O (60:15:25) for polar mixtures 
5.1.2 Chromatographic columns 
Gel filtration 
Gel filtration chromatography was performed over Sephadex LH-20 
(25-100 µm, Pharmacia Fine Chemicals) using columns 100 cm x 3 cm, 
for 2-4 g of extract, and 100 cm x 5 cm, for 5-10 g of material, and a 
peristaltic pump Pharmacia Fine Chemicals PI. The eluent was always 
methanol, at Constant flow rate (1.5 mL/min). 
Flash chromatography 
Flash chromatography was performed over Si gel 60 (230-410 pm, Merck), 
eluting with CHCl3 containing an increasing amount of MeOH. 
 
Diameter 
(mm) 
Length 
(mm) 
Material 
(mg) 
10 160 40-100 
20 160 160-400 
30 160 400-900 
40 160 800-1600 
50 160 1000-2500 
Chapter 5 Materials and Methods 
 
154 
 
HPLC 
Reversed-phase HPLC (High Performance Liquid Chromatography) 
separations were conducted on a Shimadzu LC-8A series pumping system 
equipped with a Waters R401 refractive index detector and a Shimadzu 
injector, using Waters C-18 μ-Bondapak (30 cm x 7,8 mm) and a mobile 
phase consisting of MeOH-H2O mixtures at a flow rate of 2.0-2.5 ml/min. 
5.2 Chemical-physical techniques 
5.2.1 Optical rotations 
Optical rotations were measured on a Perkin-Elmer 241 polarimeter 
equipped with a sodium lamp (589 nm) and a 1 dm microcell. 
5.3 Spectroscopic and spectrometric methods  
5.2.2 Nuclear Magnetic Resonance 
The structural determination of secondary metabolites was performed by 
one and two-dimensional NMR spectroscopy (1H, 13C, 13C DEPT, 1D-
Tolsy, COSY, HSQC, HMBC, 2D-ROESY) and confirmed by mass 
spectrometry. The 1H and 13C NMR spectra provide information about the 
number of protons present, their coupling constants and the value as well as 
information on the number of carbon atoms. With the aid of the technique 
multi impulse DEPT (distortionless Enhancement by Polarization Transfer) 
can also be determined by the number of protons attached to each carbon 
atom. The chemical shifts are reported in δ (ppm) relative to TMS (δ 0) used 
as a standard; the coupling constants (J) are measured in Hertz. 
The experiment 1D-TOCSY (Total Correlation Spectroscopy) is useful in 
spectroscopic analysis of the spin systems and in all cases in which the signal 
of a single proton is very complicated reveals in simple 1H NMR spectrum, 
this experiment allows to build a spin system selectively energizing a proton 
that, thanks to the magnetization transfer, allows to highlight all the other 
protons belonging to the same spin system. Of fundamental importance are 
the two-dimensional spectroscopy experiments. These allow you to get a 
huge increase in the spectral resolution since the signals are dispersed in two 
dimensions, providing additional information on the correlation of the same. 
The experiments used: 
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• DQF-COSY (Correlated Double Quantum Filtered-Spectroscopy), which 
allows to correlate the chemical shifts of the protons through the 
homonuclear scalar couplings, by assigning the various spin systems present 
in the molecule even when you have small pairs. 
• HSQC (Heteronuclear Single Quantum Coherence), the analogue of 
the heteronuclear COSY, which, by creating a heteronuclear coherence and 
employing the proton for signal detection, allows for the assignment of a 
spectrum 13C by the corresponding proton spectrum and vice versa, through 
the proton-carbon direct correlation; 
• HMBC (Heteronuclear Multiple Bond Coherence), the long range 
heteronuclear correlation experiment that allows to reveal the correlations 
to more than one link (2-4) between a proton and the carbon not adjacent, 
with the advantage of highlight correlations with quaternary carbons. 
A spectrometer Bruker DRX 600 (XWIN-NMR and TopSpin software), 
operating at 599.19 MHz for 1H and 150.86 MHz for 13C was used to record 
the NMR spectra. In the 1H-NMR spectra in CD3OD it was used as a 
standard the signal relating to CHD2OD to 3.34 ppm; for measurement in 
CDCl3 we were used the signal relative to CHCl3 to 7.27 ppm. The 
1H-NMR 
values are reported in δ ppm for, together with the multiplicity, to the values 
of the constants J and coupling to allocations. 
For the 13C-NMR spectra was used as reference the signal of the solvent, to 
49.0 ppm respectively for CD3OD and 77.0 ppm for CDCl3. The DEPT-135 
° experiments were performed using polarization transfer by means of a 90 
° pulse liquid to achieve only -CH groups and at 135 ° to get positive signals 
for -CH and -CH 3 groups and negative for the -CH2 groups. The delay in 
the transfer of polarization has been correlated to a mean C-H coupling of 
135 Hz. The experiment of direct correlation omonucleare (DQF-COSY, 
Double Quantum Filtered COSY) was performed using the conventional 
pulse sequence. The experiment of direct correlation heteronuclear 1H-13C 
HSQC has been realized generally on a matrix 512 x 2048, using a time 
constant of 135 Hz C-H coupling and a relaxation delay of 1.5 sec. (Kay, 
L.E. et al., 1992;). The long range heteronuclear correlation experiment 
(HMBC) was obtained using the sequence of Bax et al., A constant average 
long range of 6-8 Hz. And a matrix 512 x 2048 (Bax & Summers, 1986). 
The 1D-TOCSY experiments were obtained using a XWIN-NMR software; 
in particular, the 1D-TOCSY was performed using a Gaussian pulse 
generator using, during the mixing time, the pulse sequence of the type 
MLEV- 17 (mixing time 80-100 ms). 
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The NOESY and ROESY experiments were conducted using the 
commercial microprograms software provided with the instrument. For 
ROESY experiments it was used a 400 or 500 ms mixing time. 
5.2.3 Mass spectrometry (ESI-MS) 
Mass spectra were recorded both in positive ion mode and negative ions 
using one tool Finnigan LCQ Deca ion trap with electrospray source, 
manufactured by Thermo Finnigan (San Jose, CA, USA), Excalibur 
software for processing of the acquired data. 
The samples (isolated compounds) were analysed by direct infusion at a 
flow of 10 µL / min., Using the following instrumental parameters: capillary 
temperature 288.20 ° C; Sheath Gas Flow 45.95 psi; flow of the auxiliary 
gas 2.68; capillary voltage -25.54 V. Data were acquired either through a 
scanning MS1 through MSn, making use of the ion trap; for the 
determination of MSn it was used a collision energy of 30 eV. 
 
5.3 Solvents 
Solvents for HPLC and MS, acetonitrile and methanol, were purchased from 
JT Baker (Mallinckrodt Baker, Phillisburg, NJ), formic acid and 
trifluoroacetic acid (TFA) were purchased from Merck while the water 
nanopure (HPLC grade) was prepared by using a purification system, 
Millipore Milli-Q. For the extraction of the dried plant material they have 
been used: n-hexane, chloroform and methanol supplied from VWR 
International (Milan, Italy), as well as chloroform and methanol, used for 
the eluition of the compounds from the silica column
 
